{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T00:22:56Z","timestamp":1793924576637,"version":"4.8.0"},"reference-count":444,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T00:00:00Z","timestamp":1753920000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T00:00:00Z","timestamp":1753920000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Science Fund for Creative Research Groups of the Natural Science Foundation of Chongqing"},{"name":"National Nature Science Foundation of China; Chongqing Natural Science Fund for Distinguished Young Scholars Chinese Natural Science Foundation","id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Rodents are the most commonly used laboratory animals in medical research. However, significant evolutionary divergences between humans and rodents, particularly in the complexity of white matter connectome, which are fundamentally shaped by myelin as their major structural component, pose critical challenges in modeling the human neurological diseases. Given the divergences and central roles of myelin in pathology, a thorough reevaluation of the rodent models used in contemporary research is critical, alongside the careful selection, optimization, or de novo development of models that faithfully recapitulate human white matter disorders. In this review, we summarize the strengths and limitations of existing rodent models, emphasizing their contributions to understanding demyelinating pathologies across autoimmune, neurodegenerative, vascular, perinatal, traumatic, infectious and genetic diseases. We also overview white mater disease models using other species and human stem cells. Subsequently we discuss critical interspecies differences in white matter biology that may limit translational relevance, while highlighting how rodent models enhance our comprehension of various pathological conditions. Lastly, we outline strategies to refine rodent models through advanced genetic engineering, humanized microenvironments, and multimodal phenotyping, with the goal of progressively improving existing them to increase their preclinical translational potentials.<\/jats:p>","DOI":"10.1038\/s41419-025-07893-6","type":"journal-article","created":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T20:24:15Z","timestamp":1753993455000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Critical analysis of translational potential of rodent models of white matter pathology across a wide spectrum of human diseases"],"prefix":"10.1038","volume":"16","author":[{"given":"Wenxuan","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyue","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenmeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingwu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2592-9898","authenticated-orcid":false,"given":"Alexei","family":"Verkhratsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianqin","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,31]]},"reference":[{"key":"7893_CR1","unstructured":"Boyle R New experiments physico-mechanical, touching the spring of the air, and its effects, : (made, for the most part, in a new pneumatical engine) written by way of letter to the Right Honorable Charles Lord Vicount of Dungarvan, eldest son to the Earl of Corke. In: Line F, Hobbes T, Hall H, Lindsey G, Sachs AP, editors. The second edition. ed. Oxford : Printed by H. Hall, printer to the University, for Tho: Robinson; (1660)."},{"key":"7893_CR2","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1152\/japplphysiol.00759.2004","volume":"98","author":"JB West","year":"2005","unstructured":"West JB. Robert Boyle\u2019s landmark book of 1660 with the first experiments on rarified air. J Appl Physiol (1985). 2005;98:31\u201339.","journal-title":"J Appl Physiol (1985)"},{"key":"7893_CR3","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1152\/physiol.00005.2014","volume":"29","author":"JB West","year":"2014","unstructured":"West JB. Robert Hooke: early respiratory physiologist, polymath, and mechanical genius. Physiology. 2014;29:222\u201333.","journal-title":"Physiology"},{"key":"7893_CR4","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1126\/science.288.5464.248b","volume":"288","author":"E Pennisi","year":"2000","unstructured":"Pennisi E. A mouse chronology. Science. 2000;288:248\u201357.","journal-title":"Science"},{"key":"7893_CR5","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1242\/dmm.026120","volume":"9","author":"B Ellenbroek","year":"2016","unstructured":"Ellenbroek B, Youn J. Rodent models in neuroscience research: is it a rat race?. Dis Model Mech. 2016;9:1079\u201387.","journal-title":"Dis Model Mech"},{"key":"7893_CR6","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1002\/cne.10714","volume":"462","author":"L Marner","year":"2003","unstructured":"Marner L, Nyengaard JR, Tang Y, Pakkenberg B. Marked loss of myelinated nerve fibers in the human brain with age. J Comp Neurol. 2003;462:144\u201352.","journal-title":"J Comp Neurol"},{"key":"7893_CR7","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S0531-5565(02)00151-1","volume":"38","author":"B Pakkenberg","year":"2003","unstructured":"Pakkenberg B, Pelvig D, Marner L, Bundgaard MJ, Gundersen HJ, Nyengaard JR, et al. Aging and the human neocortex. Exp Gerontol. 2003;38:95\u201399.","journal-title":"Exp Gerontol"},{"key":"7893_CR8","doi-asserted-by":"publisher","first-page":"5621","DOI":"10.1073\/pnas.090504197","volume":"97","author":"K Zhang","year":"2000","unstructured":"Zhang K, Sejnowski TJ. A universal scaling law between gray matter and white matter of cerebral cortex. Proc Natl Acad Sci USA. 2000;97:5621\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"7893_CR9","doi-asserted-by":"crossref","unstructured":"Piekarski DJ, Zahr NM, Zhao Q, Ferizi U, Pohl KM, Sullivan EV, et al. White matter microstructural integrity continues to develop from adolescence to young adulthood in mice and humans: Same phenotype, different mechanism. Neuroimage Rep. 2023;3:100179.","DOI":"10.1016\/j.ynirp.2023.100179"},{"key":"7893_CR10","doi-asserted-by":"crossref","first-page":"725","DOI":"10.33588\/rn.5212.2010554","volume":"52","author":"J Tirapu-Ust\u00e1rroz","year":"2011","unstructured":"Tirapu-Ust\u00e1rroz J, Luna-Lario P, Hern\u00e1ez-Go\u00f1i P, Garc\u00eda-Suescun I. [Relation between white matter and cognitive functions]. Rev Neurol. 2011;52:725\u201342.","journal-title":"Rev Neurol"},{"key":"7893_CR11","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1152\/physrev.2001.81.2.871","volume":"81","author":"N Baumann","year":"2001","unstructured":"Baumann N, Pham-Dinh D. Biology of oligodendrocyte and myelin in the mammalian central nervous system. Physiol Rev. 2001;81:871\u2013927.","journal-title":"Physiol Rev"},{"key":"7893_CR12","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/BF01148316","volume":"13","author":"CS Raine","year":"1984","unstructured":"Raine CS. On the association between perinodal astrocytic processes and the node of Ranvier in the C.N.S. J Neurocytol. 1984;13:21\u201327.","journal-title":"J Neurocytol"},{"key":"7893_CR13","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1046\/j.1365-2990.1999.00200.x","volume":"25","author":"JE Merrill","year":"1999","unstructured":"Merrill JE, Scolding NJ. Mechanisms of damage to myelin and oligodendrocytes and their relevance to disease. Neuropathol Appl Neurobiol. 1999;25:435\u201358.","journal-title":"Neuropathol Appl Neurobiol"},{"key":"7893_CR14","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.tins.2023.11.003","volume":"47","author":"LK Festa","year":"2024","unstructured":"Festa LK, Grinspan JB, Jordan-Sciutto KL. White matter injury across neurodegenerative disease. Trends Neurosci. 2024;47:47\u201357.","journal-title":"Trends Neurosci"},{"key":"7893_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuroscience.2023.10.018","volume":"538","author":"H Zhang","year":"2024","unstructured":"Zhang H, Yang Y, Zhang J, Huang L, Niu Y, Chen H, et al. Oligodendrocytes play a critical role in white matter damage of vascular dementia. Neuroscience. 2024;538:1\u201310.","journal-title":"Neuroscience"},{"key":"7893_CR16","doi-asserted-by":"publisher","first-page":"3514","DOI":"10.1161\/STROKEAHA.122.039211","volume":"53","author":"GA Rosenberg","year":"2022","unstructured":"Rosenberg GA. Willis Lecture: Biomarkers for inflammatory white matter injury in Binswanger disease provide pathways to precision medicine. Stroke. 2022;53:3514\u201323.","journal-title":"Stroke"},{"key":"7893_CR17","doi-asserted-by":"publisher","first-page":"2614","DOI":"10.1016\/j.bbadis.2017.05.020","volume":"1863","author":"M Braun","year":"2017","unstructured":"Braun M, Vaibhav K, Saad NM, Fatima S, Vender JR, Baban B, et al. White matter damage after traumatic brain injury: A role for damage associated molecular patterns. Biochim Biophys Acta Mol Basis Dis. 2017;1863:2614\u201326.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"7893_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pneurobio.2010.09.005","volume":"93","author":"R Dutta","year":"2011","unstructured":"Dutta R, Trapp BD. Mechanisms of neuronal dysfunction and degeneration in multiple sclerosis. Prog Neurobiol. 2011;93:1\u201312.","journal-title":"Prog Neurobiol"},{"key":"7893_CR19","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/s41583-020-00379-8","volume":"21","author":"W Xin","year":"2020","unstructured":"Xin W, Chan JR. Myelin plasticity: sculpting circuits in learning and memory. Nat Rev Neurosci. 2020;21:682\u201394.","journal-title":"Nat Rev Neurosci"},{"key":"7893_CR20","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s00018-024-05222-2","volume":"81","author":"H Khelfaoui","year":"2024","unstructured":"Khelfaoui H, Ibaceta-Gonzalez C, Angulo MC. Functional myelin in cognition and neurodevelopmental disorders. Cell Mol Life Sci. 2024;81:181.","journal-title":"Cell Mol Life Sci"},{"key":"7893_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28326-4","volume":"13","author":"M Grotheer","year":"2022","unstructured":"Grotheer M, Rosenke M, Wu H, Kular H, Querdasi FR, Natu VS, et al. White matter myelination during early infancy is linked to spatial gradients and myelin content at birth. Nat Commun. 2022;13:997.","journal-title":"Nat Commun"},{"key":"7893_CR22","doi-asserted-by":"crossref","unstructured":"Franklin RJM, Bodini B, Goldman SA. Remyelination in the central nervous system. Cold Spring Harb Perspect Biol. 2024;16:a041371.","DOI":"10.1101\/cshperspect.a041371"},{"key":"7893_CR23","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3389\/fnmol.2015.00035","volume":"8","author":"A Alizadeh","year":"2015","unstructured":"Alizadeh A, Dyck SM, Karimi-Abdolrezaee S. Myelin damage and repair in pathologic CNS: challenges and prospects. Front Mol Neurosci. 2015;8:35.","journal-title":"Front Mol Neurosci"},{"key":"7893_CR24","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/nrn2480","volume":"9","author":"RJ Franklin","year":"2008","unstructured":"Franklin RJ, Ffrench-Constant C. Remyelination in the CNS: from biology to therapy. Nat Rev Neurosci. 2008;9:839\u201355.","journal-title":"Nat Rev Neurosci"},{"key":"7893_CR25","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.nicl.2014.06.009","volume":"6","author":"RA Brown","year":"2014","unstructured":"Brown RA, Narayanan S, Arnold DL. Imaging of repeated episodes of demyelination and remyelination in multiple sclerosis. Neuroimage Clin. 2014;6:20\u201325.","journal-title":"Neuroimage Clin"},{"key":"7893_CR26","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/dneu.22867","volume":"82","author":"JF Chen","year":"2022","unstructured":"Chen JF, Wang F, Huang NX, Xiao L, Mei F. Oligodendrocytes and myelin: Active players in neurodegenerative brains?. Dev Neurobiol. 2022;82:160\u201374.","journal-title":"Dev Neurobiol"},{"key":"7893_CR27","doi-asserted-by":"crossref","unstructured":"Kalafatakis I, Karagogeos D. Oligodendrocytes and Microglia: Key Players in Myelin Development, Damage and Repair. Biomolecules. 2021;11:1058.","DOI":"10.3390\/biom11071058"},{"key":"7893_CR28","doi-asserted-by":"crossref","unstructured":"L\u00f3pez-Muguruza E, Matute C. Alterations of Oligodendrocyte and Myelin Energy Metabolism in Multiple Sclerosis. Int J Mol Sci. 2023;24:12912.","DOI":"10.3390\/ijms241612912"},{"key":"7893_CR29","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adn9980","volume":"17","author":"Q Wang","year":"2025","unstructured":"Wang Q, Huang T, Zheng Z, Su Y, Wu Z, Zeng C, et al. Oligodendroglial precursor cells modulate immune response and early demyelination in a murine model of multiple sclerosis. Sci Transl Med. 2025;17:eadn9980.","journal-title":"Sci Transl Med"},{"key":"7893_CR30","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1007\/s12264-019-00375-8","volume":"35","author":"L Fang","year":"2019","unstructured":"Fang L, Kang X, Wang Z, Wang S, Wang J, Zhou Y, et al. Myelin Oligodendrocyte Glycoprotein-IgG Contributes to Oligodendrocytopathy in the presence of complement, distinct from astrocytopathy induced by AQP4-IgG. Neurosci Bull. 2019;35:853\u201366.","journal-title":"Neurosci Bull"},{"key":"7893_CR31","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3389\/fnmol.2019.00225","volume":"12","author":"CS Baaklini","year":"2019","unstructured":"Baaklini CS, Rawji KS, Duncan GJ, Ho MFS, Plemel JR. Central nervous system remyelination: roles of Glia and innate immune cells. Front Mol Neurosci. 2019;12:225.","journal-title":"Front Mol Neurosci"},{"key":"7893_CR32","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s13024-024-00742-8","volume":"19","author":"O Zveik","year":"2024","unstructured":"Zveik O, Rechtman A, Ganz T, Vaknin-Dembinsky A. The interplay of inflammation and remyelination: rethinking MS treatment with a focus on oligodendrocyte progenitor cells. Mol Neurodegener. 2024;19:53.","journal-title":"Mol Neurodegener"},{"key":"7893_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pneurobio.2013.04.001","volume":"106-107","author":"BD Semple","year":"2013","unstructured":"Semple BD, Blomgren K, Gimlin K, Ferriero DM, Noble-Haeusslein LJ. Brain development in rodents and humans: Identifying benchmarks of maturation and vulnerability to injury across species. Prog Neurobiol. 2013;106-107:1\u201316.","journal-title":"Prog Neurobiol"},{"key":"7893_CR34","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.tins.2013.12.001","volume":"37","author":"AM Smith","year":"2014","unstructured":"Smith AM, Dragunow M. The human side of microglia. Trends Neurosci. 2014;37:125\u201335.","journal-title":"Trends Neurosci"},{"key":"7893_CR35","doi-asserted-by":"publisher","first-page":"8288","DOI":"10.4049\/jimmunol.181.12.8288","volume":"181","author":"C Lambert","year":"2008","unstructured":"Lambert C, Desbarats J, Arbour N, Hall JA, Olivier A, Bar-Or A, et al. Dendritic cell differentiation signals induce anti-inflammatory properties in human adult microglia. J Immunol. 2008;181:8288\u201397.","journal-title":"J Immunol"},{"key":"7893_CR36","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.4049\/jimmunol.169.5.2264","volume":"169","author":"F Re","year":"2002","unstructured":"Re F, Belyanskaya SL, Riese RJ, Cipriani B, Fischer FR, Granucci F, et al. Granulocyte-macrophage colony-stimulating factor induces an expression program in neonatal microglia that primes them for antigen presentation. J Immunol. 2002;169:2264\u201373.","journal-title":"J Immunol"},{"key":"7893_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-4-10","volume":"4","author":"N Esen","year":"2007","unstructured":"Esen N, Kielian T. Effects of low dose GM-CSF on microglial inflammatory profiles to diverse pathogen-associated molecular patterns (PAMPs). J Neuroinflammation. 2007;4:10.","journal-title":"J Neuroinflammation"},{"key":"7893_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.867015","volume":"13","author":"ZB Bjornson-Hooper","year":"2022","unstructured":"Bjornson-Hooper ZB, Fragiadakis GK, Spitzer MH, Chen H, Madhireddy D, Hu K, et al. A Comprehensive Atlas of immunological differences between humans, mice, and non-human primates. Front Immunol. 2022;13:867015.","journal-title":"Front Immunol"},{"key":"7893_CR39","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1146\/annurev-immunol-041015-055531","volume":"35","author":"F Weisel","year":"2017","unstructured":"Weisel F, Shlomchik M. Memory B Cells of Mice and Humans. Annu Rev Immunol. 2017;35:255\u201384.","journal-title":"Annu Rev Immunol"},{"key":"7893_CR40","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/nyas.12118","volume":"1283","author":"M Mitsdoerffer","year":"2013","unstructured":"Mitsdoerffer M, Kuchroo V, Korn T. Immunology of neuromyelitis optica: a T cell-B cell collaboration. Ann N Y Acad Sci. 2013;1283:57\u201366.","journal-title":"Ann N Y Acad Sci"},{"key":"7893_CR41","doi-asserted-by":"publisher","first-page":"4371","DOI":"10.4049\/jimmunol.151.8.4371","volume":"151","author":"VK Kuchroo","year":"1993","unstructured":"Kuchroo VK, Martin CA, Greer JM, Ju ST, Sobel RA, Dorf ME. Cytokines and adhesion molecules contribute to the ability of myelin proteolipid protein-specific T cell clones to mediate experimental allergic encephalomyelitis. J Immunol. 1993;151:4371\u201382.","journal-title":"J Immunol"},{"key":"7893_CR42","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1038\/ni1261","volume":"6","author":"H Park","year":"2005","unstructured":"Park H, Li Z, Yang XO, Chang SH, Nurieva R, Wang YH, et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol. 2005;6:1133\u201341.","journal-title":"Nat Immunol"},{"key":"7893_CR43","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1002\/glia.20734","volume":"57","author":"MK Desai","year":"2009","unstructured":"Desai MK, Sudol KL, Janelsins MC, Mastrangelo MA, Frazer ME, Bowers WJ. Triple-transgenic Alzheimer\u2019s disease mice exhibit region-specific abnormalities in brain myelination patterns prior to appearance of amyloid and tau pathology. Glia. 2009;57:54\u201365.","journal-title":"Glia"},{"key":"7893_CR44","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1083\/jcb.200307017","volume":"164","author":"JT Lee","year":"2004","unstructured":"Lee JT, Xu J, Lee JM, Ku G, Han X, Yang DI, et al. Amyloid-beta peptide induces oligodendrocyte death by activating the neutral sphingomyelinase-ceramide pathway. J Cell Biol. 2004;164:123\u201331.","journal-title":"J Cell Biol"},{"key":"7893_CR45","first-page":"527","volume":"140","author":"J Correale","year":"2017","unstructured":"Correale J, Gait\u00e1n MI, Ysrraelit MC, Fiol MP. Progressive multiple sclerosis: from pathogenic mechanisms to treatment. Brain. 2017;140:527\u201346.","journal-title":"Brain"},{"key":"7893_CR46","doi-asserted-by":"publisher","DOI":"10.1177\/17590914221118502","volume":"14","author":"J Correale","year":"2022","unstructured":"Correale J, Ysrraelit MC. Multiple Sclerosis and Aging: The Dynamics of Demyelination and Remyelination. ASN Neuro. 2022;14:17590914221118502.","journal-title":"ASN Neuro"},{"key":"7893_CR47","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1002\/acn3.51595","volume":"9","author":"CE McMurran","year":"2022","unstructured":"McMurran CE, Mukherjee T, Brown JWL, Michell AW, Chard DT, Franklin RJM, et al. Remyelination in humans due to a retinoid-X receptor agonist is age-dependent. Ann Clin Transl Neurol. 2022;9:1090\u20134.","journal-title":"Ann Clin Transl Neurol"},{"key":"7893_CR48","doi-asserted-by":"crossref","unstructured":"Gingele S, Henkel F, Heckers S, Moellenkamp TM, H\u00fcmmert MW, Skripuletz T, et al. Delayed Demyelination and Impaired Remyelination in Aged Mice in the Cuprizone Model. Cells. 2020;9:945.","DOI":"10.3390\/cells9040945"},{"key":"7893_CR49","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.ejphar.2015.03.042","volume":"759","author":"C Procaccini","year":"2015","unstructured":"Procaccini C, De Rosa V, Pucino V, Formisano L, Matarese G. Animal models of Multiple Sclerosis. Eur J Pharm. 2015;759:182\u201391.","journal-title":"Eur J Pharm"},{"key":"7893_CR50","doi-asserted-by":"publisher","first-page":"4698","DOI":"10.1523\/JNEUROSCI.4077-15.2016","volume":"36","author":"MB Rone","year":"2016","unstructured":"Rone MB, Cui QL, Fang J, Wang LC, Zhang J, Khan D, et al. Oligodendrogliopathy in multiple sclerosis: low glycolytic metabolic rate promotes oligodendrocyte survival. J Neurosci. 2016;36:4698\u2013707.","journal-title":"J Neurosci"},{"key":"7893_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2023.106200","volume":"184","author":"S Huang","year":"2023","unstructured":"Huang S, Ren C, Luo Y, Ding Y, Ji X, Li S. New insights into the roles of oligodendrocytes regulation in ischemic stroke recovery. Neurobiol Dis. 2023;184:106200.","journal-title":"Neurobiol Dis"},{"key":"7893_CR52","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s40478-023-01601-1","volume":"11","author":"MGF Fernandes","year":"2023","unstructured":"Fernandes MGF, Mohammadnia A, Pernin F, Schmitz-Gielsdorf LE, Hodgins C, Cui QL, et al. Mechanisms of metabolic stress induced cell death of human oligodendrocytes: relevance for progressive multiple sclerosis. Acta Neuropathol Commun. 2023;11:108.","journal-title":"Acta Neuropathol Commun"},{"key":"7893_CR53","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/S0166-2236(00)01746-X","volume":"24","author":"C Matute","year":"2001","unstructured":"Matute C, Alberdi E, Domercq M, P\u00e9rez-Cerd\u00e1 F, P\u00e9rez-Samart\u00edn A, S\u00e1nchez-G\u00f3mez MV. The link between excitotoxic oligodendroglial death and demyelinating diseases. Trends Neurosci. 2001;24:224\u201330.","journal-title":"Trends Neurosci"},{"key":"7893_CR54","doi-asserted-by":"publisher","first-page":"7751","DOI":"10.1073\/pnas.0307850101","volume":"101","author":"W Deng","year":"2004","unstructured":"Deng W, Wang H, Rosenberg PA, Volpe JJ, Jensen FE. Role of metabotropic glutamate receptors in oligodendrocyte excitotoxicity and oxidative stress. Proc Natl Acad Sci USA. 2004;101:7751\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"7893_CR55","doi-asserted-by":"publisher","first-page":"9525","DOI":"10.1523\/JNEUROSCI.0579-07.2007","volume":"27","author":"C Matute","year":"2007","unstructured":"Matute C, Torre I, P\u00e9rez-Cerd\u00e1 F, P\u00e9rez-Samart\u00edn A, Alberdi E, Etxebarria E, et al. P2X(7) receptor blockade prevents ATP excitotoxicity in oligodendrocytes and ameliorates experimental autoimmune encephalomyelitis. J Neurosci. 2007;27:9525\u201333.","journal-title":"J Neurosci"},{"key":"7893_CR56","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/j.1471-4159.2006.03861.x","volume":"98","author":"W Deng","year":"2006","unstructured":"Deng W, Yue Q, Rosenberg PA, Volpe JJ, Jensen FE. Oligodendrocyte excitotoxicity determined by local glutamate accumulation and mitochondrial function. J Neurochem. 2006;98:213\u201322.","journal-title":"J Neurochem"},{"key":"7893_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2010.31","volume":"1","author":"A Ruiz","year":"2010","unstructured":"Ruiz A, Matute C, Alberdi E. Intracellular Ca2+ release through ryanodine receptors contributes to AMPA receptor-mediated mitochondrial dysfunction and ER stress in oligodendrocytes. Cell Death Dis. 2010;1:e54.","journal-title":"Cell Death Dis"},{"key":"7893_CR58","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/nm0398-291","volume":"4","author":"JW McDonald","year":"1998","unstructured":"McDonald JW, Althomsons SP, Hyrc KL, Choi DW, Goldberg MP. Oligodendrocytes from forebrain are highly vulnerable to AMPA\/kainate receptor-mediated excitotoxicity. Nat Med. 1998;4:291\u20137.","journal-title":"Nat Med"},{"key":"7893_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbih.2020.100062","volume":"4","author":"A Bernal-Chico","year":"2020","unstructured":"Bernal-Chico A, Manterola A, Cipriani R, Katona I, Matute C, Mato S. P2x7 receptors control demyelination and inflammation in the cuprizone model. Brain Behav Immun Health. 2020;4:100062.","journal-title":"Brain Behav Immun Health"},{"key":"7893_CR60","doi-asserted-by":"crossref","unstructured":"Barcelos IP, Troxell RM, Graves JS. Mitochondrial dysfunction and multiple sclerosis. Biology (Basel). 2019;8:37.","DOI":"10.3390\/biology8020037"},{"key":"7893_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2020.102189","volume":"44","author":"HB Ferreira","year":"2020","unstructured":"Ferreira HB, Neves B, Guerra IM, Moreira A, Melo T, Paiva A, et al. An overview of lipidomic analysis in different human matrices of multiple sclerosis. Mult Scler Relat Disord. 2020;44:102189.","journal-title":"Mult Scler Relat Disord"},{"key":"7893_CR62","doi-asserted-by":"publisher","first-page":"134645","DOI":"10.1016\/j.neulet.2019.134645","volume":"715","author":"TW Chapman","year":"2020","unstructured":"Chapman TW, Hill RA. Myelin plasticity in adulthood and aging. Neurosci Lett. 2020;715:134645.","journal-title":"Neurosci Lett"},{"key":"7893_CR63","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1038\/nn.2172","volume":"11","author":"S Shen","year":"2008","unstructured":"Shen S, Sandoval J, Swiss VA, Li J, Dupree J, Franklin RJ, et al. Age-dependent epigenetic control of differentiation inhibitors is critical for remyelination efficiency. Nat Neurosci. 2008;11:1024\u201334.","journal-title":"Nat Neurosci"},{"key":"7893_CR64","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/nrg.2017.19","volume":"18","author":"A Breschi","year":"2017","unstructured":"Breschi A, Gingeras TR, Guig\u00f3 R. Comparative transcriptomics in human and mouse. Nat Rev Genet. 2017;18:425\u201340.","journal-title":"Nat Rev Genet"},{"key":"7893_CR65","doi-asserted-by":"publisher","first-page":"17224","DOI":"10.1073\/pnas.1413624111","volume":"111","author":"S Lin","year":"2014","unstructured":"Lin S, Lin Y, Nery JR, Urich MA, Breschi A, Davis CA, et al. Comparison of the transcriptional landscapes between human and mouse tissues. Proc Natl Acad Sci USA. 2014;111:17224\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"7893_CR66","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/nature13992","volume":"515","author":"F Yue","year":"2014","unstructured":"Yue F, Cheng Y, Breschi A, Vierstra J, Wu W, Ryba T, et al. A comparative encyclopedia of DNA elements in the mouse genome. Nature. 2014;515:355\u201364.","journal-title":"Nature"},{"key":"7893_CR67","doi-asserted-by":"publisher","first-page":"771","DOI":"10.3389\/fimmu.2020.00771","volume":"11","author":"L Espino-Pais\u00e1n","year":"2020","unstructured":"Espino-Pais\u00e1n L, Agudo-Jim\u00e9nez T, Rosales-Mart\u00ednez I, L\u00f3pez-Cotarelo P, Garc\u00eda-Mart\u00ednez M, Dom\u00ednguez-Mozo MI, et al. A polymorphism within the MBP gene is associated with a higher relapse number in male patients of multiple sclerosis. Front Immunol. 2020;11:771.","journal-title":"Front Immunol"},{"key":"7893_CR68","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1159\/000184719","volume":"123","author":"GH Perry","year":"2008","unstructured":"Perry GH. The evolutionary significance of copy number variation in the human genome. Cytogenet Genome Res. 2008;123:283\u20137.","journal-title":"Cytogenet Genome Res"},{"key":"7893_CR69","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.bj.2021.02.003","volume":"44","author":"O P\u00f6s","year":"2021","unstructured":"P\u00f6s O, Radvanszky J, Bugly\u00f3 G, P\u00f6s Z, Rusnakova D, Nagy B, et al. DNA copy number variation: Main characteristics, evolutionary significance, and pathological aspects. Biomed J. 2021;44:548\u201359.","journal-title":"Biomed J"},{"key":"7893_CR70","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1093\/brain\/awh714","volume":"129","author":"C Confavreux","year":"2006","unstructured":"Confavreux C, Vukusic S. Age at disability milestones in multiple sclerosis. Brain. 2006;129:595\u2013605.","journal-title":"Brain"},{"key":"7893_CR71","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.nrl.2017.07.002","volume":"35","author":"L Torre-Fuentes","year":"2020","unstructured":"Torre-Fuentes L, Moreno-Jim\u00e9nez L, Pytel V, Mat\u00edas-Guiu JA, G\u00f3mez-Pinedo U, Mat\u00edas-Guiu J. Experimental models of demyelination and remyelination. Neurologia (Engl Ed). 2020;35:32\u201339.","journal-title":"Neurologia (Engl Ed)"},{"key":"7893_CR72","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1038\/nn.3168","volume":"15","author":"RM Ransohoff","year":"2012","unstructured":"Ransohoff RM. Animal models of multiple sclerosis: the good, the bad and the bottom line. Nat Neurosci. 2012;15:1074\u20137.","journal-title":"Nat Neurosci"},{"key":"7893_CR73","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/j.1750-3639.1996.tb00857.x","volume":"6","author":"M Bradl","year":"1996","unstructured":"Bradl M, Linington C. Animal models of demyelination. Brain Pathol. 1996;6:303\u201311.","journal-title":"Brain Pathol"},{"key":"7893_CR74","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/S1357-4310(99)01639-1","volume":"6","author":"R Gold","year":"2000","unstructured":"Gold R, Hartung HP, Toyka KV. Animal models for autoimmune demyelinating disorders of the nervous system. Mol Med Today. 2000;6:88\u201391.","journal-title":"Mol Med Today"},{"key":"7893_CR75","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/s41572-018-0041-4","volume":"4","author":"M Filippi","year":"2018","unstructured":"Filippi M, Bar-Or A, Piehl F, Preziosa P, Solari A, Vukusic S, et al. Multiple sclerosis. Nat Rev Dis Prim. 2018;4:43.","journal-title":"Nat Rev Dis Prim"},{"key":"7893_CR76","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1148\/rg.2018170141","volume":"38","author":"BG Dutra","year":"2018","unstructured":"Dutra BG, da Rocha AJ, Nunes RH, Maia ACMJ. Neuromyelitis Optica Spectrum Disorders: Spectrum of MR Imaging Findings and Their Differential Diagnosis. Radiographics. 2018;38:169\u201393.","journal-title":"Radiographics"},{"key":"7893_CR77","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.cell.2015.12.056","volume":"164","author":"B De Strooper","year":"2016","unstructured":"De Strooper B, Karran E. The Cellular Phase of Alzheimer\u2019s Disease. Cell. 2016;164:603\u201315.","journal-title":"Cell"},{"key":"7893_CR78","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s00401-017-1739-1","volume":"134","author":"MS van der Knaap","year":"2017","unstructured":"van der Knaap MS, Bugiani M. Leukodystrophies: a proposed classification system based on pathological changes and pathogenetic mechanisms. Acta Neuropathol. 2017;134:351\u201382.","journal-title":"Acta Neuropathol"},{"key":"7893_CR79","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1212\/WNL.0000000000000560","volume":"83","author":"FD Lublin","year":"2014","unstructured":"Lublin FD, Reingold SC, Cohen JA, Cutter GR, Sorensen PS, Thompson AJ, et al. Defining the clinical course of multiple sclerosis: the 2013 revisions. Neurology. 2014;83:278\u201386.","journal-title":"Neurology"},{"key":"7893_CR80","doi-asserted-by":"crossref","unstructured":"Barkhof F, Koeller KK IDKD Springer Series Demyelinating Diseases of the CNS (Brain and Spine). In: Hodler J, Kubik-Huch RA, von Schulthess GK (eds). Diseases of the Brain, Head and Neck, Spine 2020\u20132023: Diagnostic Imaging. Springer Copyright 2020, The Author(s). Cham (CH), 2020, pp 165-76.","DOI":"10.1007\/978-3-030-38490-6_13"},{"key":"7893_CR81","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2023.106230","volume":"184","author":"S Dedoni","year":"2023","unstructured":"Dedoni S, Scherma M, Camoglio C, Siddi C, Dazzi L, Puliga R, et al. An overall view of the most common experimental models for multiple sclerosis. Neurobiol Dis. 2023;184:106230.","journal-title":"Neurobiol Dis"},{"key":"7893_CR82","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jneumeth.2017.04.003","volume":"284","author":"JPC Hasselmann","year":"2017","unstructured":"Hasselmann JPC, Karim H, Khalaj AJ, Ghosh S, Tiwari-Woodruff SK. Consistent induction of chronic experimental autoimmune encephalomyelitis in C57BL\/6 mice for the longitudinal study of pathology and repair. J Neurosci Methods. 2017;284:71\u201384.","journal-title":"J Neurosci Methods"},{"key":"7893_CR83","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1111\/j.1476-5381.2011.01302.x","volume":"164","author":"CS Constantinescu","year":"2011","unstructured":"Constantinescu CS, Farooqi N, O\u2019Brien K, Gran B. Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS). Br J Pharm. 2011;164:1079\u2013106.","journal-title":"Br J Pharm"},{"key":"7893_CR84","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.bbrc.2008.02.161","volume":"370","author":"CB Zhao","year":"2008","unstructured":"Zhao CB, Coons SW, Cui M, Shi FD, Vollmer TL, Ma CY, et al. A new EAE model of brain demyelination induced by intracerebroventricular pertussis toxin. Biochem Biophys Res Commun. 2008;370:16\u201321.","journal-title":"Biochem Biophys Res Commun"},{"key":"7893_CR85","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.jneumeth.2007.03.013","volume":"163","author":"M Peiris","year":"2007","unstructured":"Peiris M, Monteith GR, Roberts-Thomson SJ, Cabot PJ. A model of experimental autoimmune encephalomyelitis (EAE) in C57BL\/6 mice for the characterisation of intervention therapies. J Neurosci Methods. 2007;163:245\u201354.","journal-title":"J Neurosci Methods"},{"key":"7893_CR86","doi-asserted-by":"publisher","first-page":"1403974","DOI":"10.3389\/fncel.2024.1403974","volume":"18","author":"EA Ucar","year":"2024","unstructured":"Ucar EA, Ozkan E, Shomalizadeh N, Sekerda\u011f-Kilic E, Akpunar F, Sapanci S, et al. Carbenoxolone mitigates extensive fibrosis formation in PLP-induced EAE model and multiple sclerosis serum-exposed pericyte culture. Front Cell Neurosci. 2024;18:1403974.","journal-title":"Front Cell Neurosci"},{"key":"7893_CR87","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1177\/1352458518805246","volume":"25","author":"DJ Burrows","year":"2019","unstructured":"Burrows DJ, McGown A, Jain SA, De Felice M, Ramesh TM, Sharrack B, et al. Animal models of multiple sclerosis: From rodents to zebrafish. Mult Scler. 2019;25:306\u201324.","journal-title":"Mult Scler"},{"key":"7893_CR88","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/S0165-5728(97)00207-5","volume":"84","author":"PH van der Meide","year":"1998","unstructured":"van der Meide PH, de Labie MC, Ruuls SR, Groenestein RJ, Botman CA, Olsson T, et al. Discontinuation of treatment with IFN-beta leads to exacerbation of experimental autoimmune encephalomyelitis in Lewis rats. Rapid reversal of the antiproliferative activity of IFN-beta and excessive expansion of autoreactive T cells as disease promoting mechanisms. J Neuroimmunol. 1998;84:14\u201323.","journal-title":"J Neuroimmunol"},{"key":"7893_CR89","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1002\/jnr.24224","volume":"96","author":"I Bjelobaba","year":"2018","unstructured":"Bjelobaba I, Begovic-Kupresanin V, Pekovic S, Lavrnja I. Animal models of multiple sclerosis: Focus on experimental autoimmune encephalomyelitis. J Neurosci Res. 2018;96:1021\u201342.","journal-title":"J Neurosci Res"},{"key":"7893_CR90","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1007\/s004019900163","volume":"100","author":"DM Muller","year":"2000","unstructured":"Muller DM, Pender MP, Greer JM. A neuropathological analysis of experimental autoimmune encephalomyelitis with predominant brain stem and cerebellar involvement and differences between active and passive induction. Acta Neuropathol. 2000;100:174\u201382.","journal-title":"Acta Neuropathol"},{"key":"7893_CR91","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.molmed.2010.11.006","volume":"17","author":"BA t Hart","year":"2011","unstructured":"t Hart BA, Gran B, Weissert R. EAE: imperfect but useful models of multiple sclerosis. Trends Mol Med. 2011;17:119\u201325.","journal-title":"Trends Mol Med"},{"key":"7893_CR92","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/B978-0-444-52001-2.00008-X","volume":"122","author":"AP Robinson","year":"2014","unstructured":"Robinson AP, Harp CT, Noronha A, Miller SD. The experimental autoimmune encephalomyelitis (EAE) model of MS: utility for understanding disease pathophysiology and treatment. Handb Clin Neurol. 2014;122:173\u201389.","journal-title":"Handb Clin Neurol"},{"key":"7893_CR93","doi-asserted-by":"crossref","unstructured":"Papazian I, Kourouvani M, Dagkonaki A, Gouzouasis V, Dimitrakopoulou L, Markoglou N, et al. Spontaneous human CD8 T cell and autoimmune encephalomyelitis-induced CD4\/CD8 T cell lesions in the brain and spinal cord of HLA-DRB1*15-positive multiple sclerosis humanized immune system mice. Elife. 2024;12:RP88826.","DOI":"10.7554\/eLife.88826"},{"key":"7893_CR94","doi-asserted-by":"publisher","first-page":"3104","DOI":"10.1016\/j.neuron.2021.07.018","volume":"109","author":"J Niu","year":"2021","unstructured":"Niu J, Yu G, Wang X, Xia W, Wang Y, Hoi KK, et al. Oligodendroglial ring finger protein Rnf43 is an essential injury-specific regulator of oligodendrocyte maturation. Neuron. 2021;109:3104\u201318.e3106.","journal-title":"Neuron"},{"key":"7893_CR95","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/s41593-019-0369-4","volume":"22","author":"J Niu","year":"2019","unstructured":"Niu J, Tsai HH, Hoi KK, Huang N, Yu G, Kim K, et al. Aberrant oligodendroglial-vascular interactions disrupt the blood-brain barrier, triggering CNS inflammation. Nat Neurosci. 2019;22:709\u201318.","journal-title":"Nat Neurosci"},{"key":"7893_CR96","doi-asserted-by":"crossref","unstructured":"Zhan J, Mann T, Joost S, Behrangi N, Frank M, Kipp M. The Cuprizone Model: Dos and Do Nots. Cells. 2020;9:843.","DOI":"10.3390\/cells9040843"},{"key":"7893_CR97","doi-asserted-by":"publisher","first-page":"129","DOI":"10.2174\/1570159X15666170717120343","volume":"17","author":"JM Vega-Riquer","year":"2019","unstructured":"Vega-Riquer JM, Mendez-Victoriano G, Morales-Luckie RA, Gonzalez-Perez O. Five decades of Cuprizone, an updated model to replicate demyelinating diseases. Curr Neuropharmacol. 2019;17:129\u201341.","journal-title":"Curr Neuropharmacol"},{"key":"7893_CR98","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/j.1750-3639.2001.tb00385.x","volume":"11","author":"GK Matsushima","year":"2001","unstructured":"Matsushima GK, Morell P. The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system. Brain Pathol. 2001;11:107\u201316.","journal-title":"Brain Pathol"},{"key":"7893_CR99","doi-asserted-by":"crossref","unstructured":"Leo H, Kipp M. Remyelination in multiple sclerosis: findings in the Cuprizone model. Int J Mol Sci. 2022;23:16093.","DOI":"10.3390\/ijms232416093"},{"key":"7893_CR100","doi-asserted-by":"publisher","first-page":"14965","DOI":"10.1523\/JNEUROSCI.3794-09.2009","volume":"29","author":"AM Soulika","year":"2009","unstructured":"Soulika AM, Lee E, McCauley E, Miers L, Bannerman P, Pleasure D. Initiation and progression of axonopathy in experimental autoimmune encephalomyelitis. J Neurosci. 2009;29:14965\u201379.","journal-title":"J Neurosci"},{"key":"7893_CR101","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2022.995477","volume":"15","author":"M Gharagozloo","year":"2022","unstructured":"Gharagozloo M, Mace JW, Calabresi PA. Animal models to investigate the effects of inflammation on remyelination in multiple sclerosis. Front Mol Neurosci. 2022;15:995477.","journal-title":"Front Mol Neurosci"},{"key":"7893_CR102","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2022.102194","volume":"63","author":"M Gharagozloo","year":"2022","unstructured":"Gharagozloo M, Bannon R, Calabresi PA. Breaking the barriers to remyelination in multiple sclerosis. Curr Opin Pharm. 2022;63:102194.","journal-title":"Curr Opin Pharm"},{"key":"7893_CR103","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/glia.23245","volume":"66","author":"JR Plemel","year":"2018","unstructured":"Plemel JR, Michaels NJ, Weishaupt N, Caprariello AV, Keough MB, Rogers JA, et al. Mechanisms of lysophosphatidylcholine-induced demyelination: A primary lipid disrupting myelinopathy. Glia. 2018;66:327\u201347.","journal-title":"Glia"},{"key":"7893_CR104","doi-asserted-by":"publisher","DOI":"10.1016\/j.xpro.2022.101141","volume":"3","author":"M Bosch-Queralt","year":"2022","unstructured":"Bosch-Queralt M, Tiwari V, Damkou A, Vacul\u010diakov\u00e1 L, Alexopoulos I, Simons M. A fluorescence microscopy-based protocol for volumetric measurement of lysolecithin lesion-associated de- and re-myelination in mouse brain. STAR Protoc. 2022;3:101141.","journal-title":"STAR Protoc"},{"key":"7893_CR105","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1242\/jcs.10.2.535","volume":"10","author":"SM Hall","year":"1972","unstructured":"Hall SM. The effect of injections of lysophosphatidyl choline into white matter of the adult mouse spinal cord. J Cell Sci. 1972;10:535\u201346.","journal-title":"J Cell Sci"},{"key":"7893_CR106","first-page":"193","volume":"318","author":"WF Blakemore","year":"2008","unstructured":"Blakemore WF, Franklin RJ. Remyelination in experimental models of toxin-induced demyelination. Curr Top Microbiol Immunol. 2008;318:193\u2013212.","journal-title":"Curr Top Microbiol Immunol"},{"key":"7893_CR107","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1212\/CPJ.0000000000000560","volume":"9","author":"H Abboud","year":"2019","unstructured":"Abboud H, Yu XX, Knusel K, Fernandez HH, Cohen JA. Movement disorders in early MS and related diseases: A prospective observational study. Neurol Clin Pr. 2019;9:24\u201331.","journal-title":"Neurol Clin Pr"},{"key":"7893_CR108","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1111\/jnc.15142","volume":"156","author":"R Yamazaki","year":"2021","unstructured":"Yamazaki R, Ohno N, Huang JK. Acute motor deficit and subsequent remyelination-associated recovery following internal capsule demyelination in mice. J Neurochem. 2021;156:917\u201328.","journal-title":"J Neurochem"},{"key":"7893_CR109","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1267\/ahc.24-00005","volume":"57","author":"R Yamazaki","year":"2024","unstructured":"Yamazaki R, Ohno N. The Mouse Model of Internal Capsule Demyelination: A Novel Tool for Investigating Motor Functional Changes Caused by Demyelination and for Evaluating Drugs That Promote Remyelination. Acta Histochem Cytochem. 2024;57:1\u20135.","journal-title":"Acta Histochem Cytochem"},{"key":"7893_CR110","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/S0074-7742(07)79029-3","volume":"79","author":"DM Wingerchuk","year":"2007","unstructured":"Wingerchuk DM. Neuromyelitis optica: new findings on pathogenesis. Int Rev Neurobiol. 2007;79:665\u201388.","journal-title":"Int Rev Neurobiol"},{"key":"7893_CR111","doi-asserted-by":"publisher","DOI":"10.1111\/jon.13250","volume":"35","author":"CC Tsai","year":"2025","unstructured":"Tsai CC, Combes A, McMullen K, Kolind SH, Traboulsee AL. Exploring subcortical pathology and processing speed in neuromyelitis optica spectrum disorder with myelin water imaging. J Neuroimaging. 2025;35:e13250.","journal-title":"J Neuroimaging"},{"key":"7893_CR112","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/B978-0-12-802395-2.00019-5","volume":"145","author":"R H\u00f6ftberger","year":"2017","unstructured":"H\u00f6ftberger R, Lassmann H. Inflammatory demyelinating diseases of the central nervous system. Handb Clin Neurol. 2017;145:263\u201383.","journal-title":"Handb Clin Neurol"},{"key":"7893_CR113","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/B978-0-443-19102-2.00001-6","volume":"210","author":"L Zhang","year":"2025","unstructured":"Zhang L, Verkhratsky A, Shi FD. Astrocytes and microglia in multiple sclerosis and neuromyelitis optica. Handb Clin Neurol. 2025;210:133\u201345.","journal-title":"Handb Clin Neurol"},{"key":"7893_CR114","doi-asserted-by":"publisher","DOI":"10.1111\/jnc.70080","volume":"169","author":"A Verkhratsky","year":"2025","unstructured":"Verkhratsky A, Li B, Niu J, Lin SS, Su Y, Jin WN, et al. Neuroglial Advances: New Roles for Established Players. J Neurochem. 2025;169:e70080.","journal-title":"J Neurochem"},{"key":"7893_CR115","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/bpa.12793","volume":"30","author":"T Duan","year":"2020","unstructured":"Duan T, Verkman AS. Experimental animal models of aquaporin-4-IgG-seropositive neuromyelitis optica spectrum disorders: progress and shortcomings. Brain Pathol. 2020;30:13\u201325.","journal-title":"Brain Pathol"},{"key":"7893_CR116","doi-asserted-by":"crossref","unstructured":"Huang TL, Wang JK, Chang PY, Hsu YR, Lin CH, Lin KH, et al. Neuromyelitis optica spectrum disorder: from basic research to clinical perspectives. Int J Mol Sci. 2022;23:7908.","DOI":"10.3390\/ijms23147908"},{"key":"7893_CR117","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s40478-015-0259-2","volume":"3","author":"K Kurosawa","year":"2015","unstructured":"Kurosawa K, Misu T, Takai Y, Sato DK, Takahashi T, Abe Y, et al. Severely exacerbated neuromyelitis optica rat model with extensive astrocytopathy by high affinity anti-aquaporin-4 monoclonal antibody. Acta Neuropathol Commun. 2015;3:82.","journal-title":"Acta Neuropathol Commun"},{"key":"7893_CR118","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1111\/bpa.12098","volume":"24","author":"M Bradl","year":"2014","unstructured":"Bradl M, Lassmann H. Experimental models of neuromyelitis optica. Brain Pathol. 2014;24:74\u201382.","journal-title":"Brain Pathol"},{"key":"7893_CR119","doi-asserted-by":"publisher","first-page":"354","DOI":"10.4103\/NRR.NRR-D-23-01325","volume":"20","author":"L Xu","year":"2025","unstructured":"Xu L, Xu H, Tang C. Aquaporin-4-IgG-seropositive neuromyelitis optica spectrum disorders: progress of experimental models based on disease pathogenesis. Neural Regen Res. 2025;20:354\u201365.","journal-title":"Neural Regen Res"},{"key":"7893_CR120","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1002\/ana.21802","volume":"66","author":"JL Bennett","year":"2009","unstructured":"Bennett JL, Lam C, Kalluri SR, Saikali P, Bautista K, Dupree C, et al. Intrathecal pathogenic anti-aquaporin-4 antibodies in early neuromyelitis optica. Ann Neurol. 2009;66:617\u201329.","journal-title":"Ann Neurol"},{"key":"7893_CR121","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2377-13-104","volume":"13","author":"H Saini","year":"2013","unstructured":"Saini H, Rifkin R, Gorelik M, Huang H, Ferguson Z, Jones MV, et al. Passively transferred human NMO-IgG exacerbates demyelination in mouse experimental autoimmune encephalomyelitis. BMC Neurol. 2013;13:104.","journal-title":"BMC Neurol"},{"key":"7893_CR122","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.msard.2019.02.025","volume":"30","author":"CL Lee","year":"2019","unstructured":"Lee CL, Wang KC, Chen SJ, Chen CM, Tsai CP, Chen SY. Repetitive intrathecal injection of human NMO-IgG with complement exacerbates disease severity with NMO pathology in experimental allergic encephalomyelitis mice. Mult Scler Relat Disord. 2019;30:225\u201330.","journal-title":"Mult Scler Relat Disord"},{"key":"7893_CR123","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/brain\/awp309","volume":"133","author":"S Saadoun","year":"2010","unstructured":"Saadoun S, Waters P, Bell BA, Vincent A, Verkman AS, Papadopoulos MC. Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice. Brain. 2010;133:349\u201361.","journal-title":"Brain"},{"key":"7893_CR124","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.703249","volume":"12","author":"SF Soerensen","year":"2021","unstructured":"Soerensen SF, Wirenfeldt M, Wlodarczyk A, Moerch MT, Khorooshi R, Arengoth DS, et al. An Experimental Model of Neuromyelitis Optica Spectrum Disorder-Optic Neuritis: Insights Into Disease Mechanisms. Front Neurol. 2021;12:703249.","journal-title":"Front Neurol"},{"key":"7893_CR125","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.exer.2018.06.011","volume":"175","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Bao Y, Qiu W, Peng L, Fang L, Xu Y, et al. Structural and visual functional deficits in a rat model of neuromyelitis optica spectrum disorders related optic neuritis. Exp Eye Res. 2018;175:124\u201332.","journal-title":"Exp Eye Res"},{"key":"7893_CR126","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-022-02623-7","volume":"19","author":"Y Morita","year":"2022","unstructured":"Morita Y, Itokazu T, Nakanishi T, Hiraga SI, Yamashita T. A novel aquaporin-4-associated optic neuritis rat model with severe pathological and functional manifestations. J Neuroinflammation. 2022;19:263.","journal-title":"J Neuroinflammation"},{"key":"7893_CR127","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-016-0577-8","volume":"13","author":"R Marignier","year":"2016","unstructured":"Marignier R, Ruiz A, Cavagna S, Nicole A, Watrin C, Touret M, et al. Neuromyelitis optica study model based on chronic infusion of autoantibodies in rat cerebrospinal fluid. J Neuroinflammation. 2016;13:111.","journal-title":"J Neuroinflammation"},{"key":"7893_CR128","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adg5116","volume":"16","author":"S Jiang","year":"2024","unstructured":"Jiang S, Li X, Li Y, Chang Z, Yuan M, Zhang Y, et al. APOE from patient-derived astrocytic extracellular vesicles alleviates neuromyelitis optica spectrum disorder in a mouse model. Sci Transl Med. 2024;16:eadg5116.","journal-title":"Sci Transl Med"},{"key":"7893_CR129","doi-asserted-by":"publisher","first-page":"14781","DOI":"10.1073\/pnas.1617859114","volume":"113","author":"SA Sagan","year":"2016","unstructured":"Sagan SA, Winger RC, Cruz-Herranz A, Nelson PA, Hagberg S, Miller CN, et al. Tolerance checkpoint bypass permits emergence of pathogenic T cells to neuromyelitis optica autoantigen aquaporin-4. Proc Natl Acad Sci USA. 2016;113:14781\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"7893_CR130","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2023.578109","volume":"380","author":"K Serizawa","year":"2023","unstructured":"Serizawa K, Miyake S, Katsura Y, Yorozu K, Kurasawa M, Tomizawa-Shinohara H, et al. Intradermal AQP4 peptide immunization induces clinical features of neuromyelitis optica spectrum disorder in mice. J Neuroimmunol. 2023;380:578109.","journal-title":"J Neuroimmunol"},{"key":"7893_CR131","doi-asserted-by":"publisher","first-page":"e0167952","DOI":"10.1371\/journal.pone.0167952","volume":"11","author":"T Yasuda","year":"2016","unstructured":"Yasuda T, Ura T, Taniguchi M, Yoshida H. Intradermal Delivery of antigens enhances specific IgG and diminishes IgE production: potential use for vaccination and allergy immunotherapy. PLoS One. 2016;11:e0167952.","journal-title":"PLoS One"},{"key":"7893_CR132","doi-asserted-by":"publisher","first-page":"389","DOI":"10.3389\/fneur.2020.00389","volume":"11","author":"APB da Silva","year":"2020","unstructured":"da Silva APB, Silva RBM, Goi LDS, Molina RD, Machado DC, Sato DK. Experimental models of neuroimmunological disorders: a review. Front Neurol. 2020;11:389.","journal-title":"Front Neurol"},{"key":"7893_CR133","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2306572120","volume":"120","author":"SA Sagan","year":"2023","unstructured":"Sagan SA, Moinfar Z, Moseley CE, Dandekar R, Spencer CM, Verkman AS, et al. T cell deletional tolerance restricts AQP4 but not MOG CNS autoimmunity. Proc Natl Acad Sci USA. 2023;120:e2306572120.","journal-title":"Proc Natl Acad Sci USA"},{"key":"7893_CR134","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1007\/s00401-013-1204-8","volume":"127","author":"N Asavapanumas","year":"2014","unstructured":"Asavapanumas N, Ratelade J, Verkman AS. Unique neuromyelitis optica pathology produced in na\u00efve rats by intracerebral administration of NMO-IgG. Acta Neuropathol. 2014;127:539\u201351.","journal-title":"Acta Neuropathol"},{"key":"7893_CR135","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.727750","volume":"12","author":"W Xiang","year":"2021","unstructured":"Xiang W, Xie C, Luo J, Zhang W, Zhao X, Yang H, et al. Low frequency ultrasound with injection of NMO-IgG and complement produces lesions different from experimental autoimmune Encephalomyelitis mice. Front Immunol. 2021;12:727750.","journal-title":"Front Immunol"},{"key":"7893_CR136","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2023.1216477","volume":"14","author":"FC Oertel","year":"2023","unstructured":"Oertel FC, Hastermann M, Paul F. Delimiting MOGAD as a disease entity using translational imaging. Front Neurol. 2023;14:1216477.","journal-title":"Front Neurol"},{"key":"7893_CR137","first-page":"615","volume":"62","author":"Y Utumi","year":"2010","unstructured":"Utumi Y, Iseki E, Murayama N, Ichimiya Y, Arai H. [Limbic encephalitis caused by herpes simplex virus infection after vaccination against the influenza virus]. Brain Nerve. 2010;62:615\u20139.","journal-title":"Brain Nerve"},{"key":"7893_CR138","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1159\/000453396","volume":"77","author":"B Niemeyer","year":"2017","unstructured":"Niemeyer B, Niemeyer R, Borges R, Marchiori E. Acute disseminated Encephalomyelitis following Zika virus infection. Eur Neurol. 2017;77:45\u201346.","journal-title":"Eur Neurol"},{"key":"7893_CR139","first-page":"340","volume":"110","author":"F El Ouni","year":"2010","unstructured":"El Ouni F, Hassayoun S, Gaha M, Mhabrech H, Mrad-Dali K, Tlili K. Acute disseminated encephalomyelitis following herpes simplex encephalitis. Acta Neurol Belg. 2010;110:340\u20134.","journal-title":"Acta Neurol Belg"},{"key":"7893_CR140","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1007\/s00115-004-1842-0","volume":"76","author":"O St\u00fcve","year":"2005","unstructured":"St\u00fcve O, Nessler S, Hartung HP, Hemmer B, Wiendl H, Kieseier BC. [Acute disseminated encephalomyelitis. Pathogenesis, diagnosis, treatment, and prognosis]. Nervenarzt. 2005;76:701\u20137.","journal-title":"Nervenarzt"},{"key":"7893_CR141","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2024.114851","volume":"379","author":"I Djabirska","year":"2024","unstructured":"Djabirska I, Delaval L, Tromme A, Blomet J, Desmecht D, Van Laere AS. Longitudinal quantitative assessment of TMEV-IDD-induced MS phenotypes in two inbred mouse strains using automated video tracking technology. Exp Neurol. 2024;379:114851.","journal-title":"Exp Neurol"},{"key":"7893_CR142","doi-asserted-by":"crossref","unstructured":"Leitzen E, Jin W, Herder V, Beineke A, Elmarabet SA, Baumg\u00e4rtner W, et al. Comparison of reported spinal cord lesions in progressive multiple sclerosis with Theiler\u2019s Murine Encephalomyelitis virus induced demyelinating disease. Int J Mol Sci. 2019;20:989.","DOI":"10.3390\/ijms20040989"},{"key":"7893_CR143","doi-asserted-by":"publisher","first-page":"e0188013","DOI":"10.1371\/journal.pone.0188013","volume":"12","author":"J Dunham","year":"2017","unstructured":"Dunham J, van de Vis R, Bauer J, Wubben J, van Driel N, Laman JD, et al. Severe oxidative stress in an acute inflammatory demyelinating model in the rhesus monkey. PLoS One. 2017;12:e0188013.","journal-title":"PLoS One"},{"key":"7893_CR144","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s00401-014-1263-5","volume":"128","author":"C Schuh","year":"2014","unstructured":"Schuh C, Wimmer I, Hametner S, Haider L, Van Dam AM, Liblau RS, et al. Oxidative tissue injury in multiple sclerosis is only partly reflected in experimental disease models. Acta Neuropathol. 2014;128:247\u201366.","journal-title":"Acta Neuropathol"},{"key":"7893_CR145","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1023\/A:1025731309829","volume":"31","author":"A Peters","year":"2002","unstructured":"Peters A. The effects of normal aging on myelin and nerve fibers: a review. J Neurocytol. 2002;31:581\u201393.","journal-title":"J Neurocytol"},{"key":"7893_CR146","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/j.neurobiolaging.2009.08.007","volume":"32","author":"G Bartzokis","year":"2011","unstructured":"Bartzokis G. Alzheimer\u2019s disease as homeostatic responses to age-related myelin breakdown. Neurobiol aging. 2011;32:1341\u201371.","journal-title":"Neurobiol aging"},{"key":"7893_CR147","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.ceb.2021.05.003","volume":"73","author":"BLL Clayton","year":"2021","unstructured":"Clayton BLL, Tesar PJ. Oligodendrocyte progenitor cell fate and function in development and disease. Curr Opin Cell Biol. 2021;73:35\u201340.","journal-title":"Curr Opin Cell Biol"},{"key":"7893_CR148","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1007\/s00429-023-02695-y","volume":"228","author":"M Caldwell","year":"2023","unstructured":"Caldwell M, Ayo-Jibunoh V, Mendoza JC, Brimblecombe KR, Reynolds LM, Zhu Jiang XY, et al. Axo-glial interactions between midbrain dopamine neurons and oligodendrocyte lineage cells in the anterior corpus callosum. Brain Struct Funct. 2023;228:1993\u20132006.","journal-title":"Brain Struct Funct"},{"key":"7893_CR149","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1056\/NEJM2003ra020003","volume":"348","author":"RL Nussbaum","year":"2003","unstructured":"Nussbaum RL, Ellis CE. Alzheimer\u2019s disease and Parkinson\u2019s disease. N Engl J Med. 2003;348:1356\u201364.","journal-title":"N Engl J Med"},{"key":"7893_CR150","first-page":"289","volume":"47","author":"RA Armstrong","year":"2009","unstructured":"Armstrong RA. The molecular biology of senile plaques and neurofibrillary tangles in Alzheimer\u2019s disease. Folia Neuropathol. 2009;47:289\u201399.","journal-title":"Folia Neuropathol"},{"key":"7893_CR151","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/nrn2967","volume":"12","author":"LM Ittner","year":"2011","unstructured":"Ittner LM, G\u00f6tz J. Amyloid-\u03b2 and tau-a toxic pas de deux in Alzheimer\u2019s disease. Nat Rev Neurosci. 2011;12:65\u201372.","journal-title":"Nat Rev Neurosci"},{"key":"7893_CR152","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1002\/2211-5463.13661","volume":"14","author":"N Kawade","year":"2024","unstructured":"Kawade N, Yamanaka K. Novel insights into brain lipid metabolism in Alzheimer\u2019s disease: Oligodendrocytes and white matter abnormalities. FEBS Open Bio. 2024;14:194\u2013216.","journal-title":"FEBS Open Bio"},{"key":"7893_CR153","doi-asserted-by":"crossref","unstructured":"Moscoso A, Silva-Rodr\u00edguez J, Aldrey JM, Cort\u00e9s J, P\u00edas-Peleteiro JM, Ruibal \u00c1, et al. 18) F-florbetapir PET as a marker of myelin integrity across the Alzheimer\u2019s disease spectrum. Eur J Nucl Med Mol Imaging. 2022;49:1242\u201353.","DOI":"10.1007\/s00259-021-05493-y"},{"key":"7893_CR154","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s40478-018-0515-3","volume":"6","author":"SE Nasrabady","year":"2018","unstructured":"Nasrabady SE, Rizvi B, Goldman JE, Brickman AM. White matter changes in Alzheimer\u2019s disease: a focus on myelin and oligodendrocytes. Acta Neuropathol Commun. 2018;6:22.","journal-title":"Acta Neuropathol Commun"},{"key":"7893_CR155","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1001\/jamaneurol.2016.3232","volume":"74","author":"DC Dean 3rd","year":"2017","unstructured":"Dean DC 3rd, Hurley SA, Kecskemeti SR, O\u2019Grady JP, Canda C, Davenport-Sis NJ, et al. Association of amyloid pathology with myelin alteration in preclinical Alzheimer disease. JAMA Neurol. 2017;74:41\u201349.","journal-title":"JAMA Neurol"},{"key":"7893_CR156","doi-asserted-by":"publisher","first-page":"698","DOI":"10.14336\/AD.2023.0628","volume":"15","author":"Z Huang","year":"2024","unstructured":"Huang Z, Jordan JD, Zhang Q. Myelin pathology in Alzheimer\u2019s disease: potential therapeutic opportunities. Aging Dis. 2024;15:698\u2013713.","journal-title":"Aging Dis"},{"key":"7893_CR157","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1002\/alz.12178","volume":"17","author":"M Habes","year":"2021","unstructured":"Habes M, Pomponio R, Shou H, Doshi J, Mamourian E, Erus G, et al. The Brain Chart of Aging: Machine-learning analytics reveals links between brain aging, white matter disease, amyloid burden, and cognition in the iSTAGING consortium of 10,216 harmonized MR scans. Alzheimers Dement. 2021;17:89\u2013102.","journal-title":"Alzheimers Dement"},{"key":"7893_CR158","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41586-023-06120-6","volume":"618","author":"C Depp","year":"2023","unstructured":"Depp C, Sun T, Sasmita AO, Spieth L, Berghoff SA, Nazarenko T, et al. Myelin dysfunction drives amyloid-\u03b2 deposition in models of Alzheimer\u2019s disease. Nature. 2023;618:349\u201357.","journal-title":"Nature"},{"key":"7893_CR159","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s13024-024-00759-z","volume":"19","author":"A Ishii","year":"2024","unstructured":"Ishii A, Pathoulas JA, MoustafaFathy Omar O, Ge Y, Yao AY, Pantalena T, et al. Contribution of amyloid deposition from oligodendrocytes in a mouse model of Alzheimer\u2019s disease. Mol Neurodegener. 2024;19:83.","journal-title":"Mol Neurodegener"},{"key":"7893_CR160","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.3233\/JAD-240058","volume":"98","author":"B Polis","year":"2024","unstructured":"Polis B, Samson AO. Addressing the discrepancies between animal models and human alzheimer\u2019s disease pathology: implications for translational research. J Alzheimers Dis. 2024;98:1199\u2013218.","journal-title":"J Alzheimers Dis"},{"key":"7893_CR161","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.15252\/embj.201797397","volume":"36","author":"H Sasaguri","year":"2017","unstructured":"Sasaguri H, Nilsson P, Hashimoto S, Nagata K, Saito T, De Strooper B, et al. APP mouse models for Alzheimer\u2019s disease preclinical studies. Embo j. 2017;36:2473\u201387.","journal-title":"Embo j"},{"key":"7893_CR162","doi-asserted-by":"crossref","unstructured":"P\u00e1dua MS, Guil-Guerrero JL, Prates JAM, Lopes PA. Insights on the use of transgenic mice models in Alzheimer\u2019s disease research. Int J Mol Sci. 2024;25:2805.","DOI":"10.3390\/ijms25052805"},{"key":"7893_CR163","doi-asserted-by":"publisher","first-page":"10129","DOI":"10.1523\/JNEUROSCI.1202-06.2006","volume":"26","author":"H Oakley","year":"2006","unstructured":"Oakley H, Cole SL, Logan S, Maus E, Shao P, Craft J, et al. Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer\u2019s disease mutations: potential factors in amyloid plaque formation. J Neurosci. 2006;26:10129\u201340.","journal-title":"J Neurosci"},{"key":"7893_CR164","doi-asserted-by":"publisher","first-page":"908","DOI":"10.4103\/1673-5374.232486","volume":"13","author":"YX Dong","year":"2018","unstructured":"Dong YX, Zhang HY, Li HY, Liu PH, Sui Y, Sun XH. Association between Alzheimer\u2019s disease pathogenesis and early demyelination and oligodendrocyte dysfunction. Neural Regen Res. 2018;13:908\u201314.","journal-title":"Neural Regen Res"},{"key":"7893_CR165","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2020.575082","volume":"14","author":"I Chacon-De-La-Rocha","year":"2020","unstructured":"Chacon-De-La-Rocha I, Fryatt G, Rivera AD, Verkhratsky A, Raineteau O, Gomez-Nicola D, et al. Accelerated Dystrophy and Decay of Oligodendrocyte Precursor Cells in the APP\/PS1 Model of Alzheimer\u2019s-Like Pathology. Front Cell Neurosci. 2020;14:575082.","journal-title":"Front Cell Neurosci"},{"key":"7893_CR166","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/j.neurobiolaging.2003.08.012","volume":"24","author":"S Oddo","year":"2003","unstructured":"Oddo S, Caccamo A, Kitazawa M, Tseng BP, LaFerla FM. Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer\u2019s disease. Neurobiol Aging. 2003;24:1063\u201370.","journal-title":"Neurobiol Aging"},{"key":"7893_CR167","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2023.114505","volume":"368","author":"S Tian","year":"2023","unstructured":"Tian S, Ye T, Cheng X. The behavioral, pathological and therapeutic features of the triple transgenic Alzheimer\u2019s disease (3 \u00d7 Tg-AD) mouse model strain. Exp Neurol. 2023;368:114505.","journal-title":"Exp Neurol"},{"key":"7893_CR168","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.neurobiolaging.2020.05.016","volume":"94","author":"I Vanzulli","year":"2020","unstructured":"Vanzulli I, Papanikolaou M, De-La-Rocha IC, Pieropan F, Rivera AD, Gomez-Nicola D, et al. Disruption of oligodendrocyte progenitor cells is an early sign of pathology in the triple transgenic mouse model of Alzheimer\u2019s disease. Neurobiol Aging. 2020;94:130\u20139.","journal-title":"Neurobiol Aging"},{"key":"7893_CR169","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.3233\/JAD-143120","volume":"45","author":"BC Richard","year":"2015","unstructured":"Richard BC, Kurdakova A, Baches S, Bayer TA, Weggen S, Wirths O. Gene dosage dependent aggravation of the neurological phenotype in the 5XFAD Mouse Model of Alzheimer\u2019s disease. J Alzheimers Dis. 2015;45:1223\u201336.","journal-title":"J Alzheimers Dis"},{"key":"7893_CR170","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.24272\/j.issn.2095-8137.2022.289","volume":"43","author":"ZY Chen","year":"2022","unstructured":"Chen ZY, Zhang Y. Animal models of Alzheimer\u2019s disease: Applications, evaluation, and perspectives. Zool Res. 2022;43:1026\u201340.","journal-title":"Zool Res"},{"key":"7893_CR171","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2024.149083","volume":"1841","author":"ML Russo","year":"2024","unstructured":"Russo ML, Ayala G, Neal D, Rogalsky AE, Ahmad S, Musial TF, et al. Alzheimer\u2019s-linked axonal changes accompany elevated antidromic action potential failure rate in aged mice. Brain Res. 2024;1841:149083.","journal-title":"Brain Res"},{"key":"7893_CR172","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2022.105361","volume":"158","author":"N Watamura","year":"2022","unstructured":"Watamura N, Sato K, Saido TC. Mouse models of Alzheimer\u2019s disease for preclinical research. Neurochem Int. 2022;158:105361.","journal-title":"Neurochem Int"},{"key":"7893_CR173","doi-asserted-by":"crossref","unstructured":"Morrissey ZD, Gao J, Shetti A, Li W, Zhan L, Li W, et al. Temporal alterations in white matter in an app knock-in mouse model of Alzheimer\u2019s disease. eNeuro. 2024;11:ENEURO.0496-23.2024.","DOI":"10.1523\/ENEURO.0496-23.2024"},{"key":"7893_CR174","doi-asserted-by":"crossref","unstructured":"Chia SJ, Tan EK, Chao YX. Historical perspective: Models of Parkinson\u2019s disease. Int J Mol Sci. 2020;21:2464.","DOI":"10.3390\/ijms21072464"},{"key":"7893_CR175","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1038\/nm.2165","volume":"16","author":"JA Obeso","year":"2010","unstructured":"Obeso JA, Rodriguez-Oroz MC, Goetz CG, Marin C, Kordower JH, Rodriguez M, et al. Missing pieces in the Parkinson\u2019s disease puzzle. Nat Med. 2010;16:653\u201361.","journal-title":"Nat Med"},{"key":"7893_CR176","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/nature23664","volume":"548","author":"T Kikuchi","year":"2017","unstructured":"Kikuchi T, Morizane A, Doi D, Magotani H, Onoe H, Hayashi T, et al. Human iPS cell-derived dopaminergic neurons function in a primate Parkinson\u2019s disease model. Nature. 2017;548:592\u20136.","journal-title":"Nature"},{"key":"7893_CR177","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/42166","volume":"388","author":"MG Spillantini","year":"1997","unstructured":"Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M. Alpha-synuclein in Lewy bodies. Nature. 1997;388:839\u201340.","journal-title":"Nature"},{"key":"7893_CR178","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.cca.2022.02.006","volume":"529","author":"R Chen","year":"2022","unstructured":"Chen R, Gu X, Wang X. \u03b1-Synuclein in Parkinson\u2019s disease and advances in detection. Clin Chim Acta. 2022;529:76\u201386.","journal-title":"Clin Chim Acta"},{"key":"7893_CR179","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1038\/s41531-023-00592-z","volume":"9","author":"K Yang","year":"2023","unstructured":"Yang K, Wu Z, Long J, Li W, Wang X, Hu N, et al. White matter changes in Parkinson\u2019s disease. NPJ Parkinsons Dis. 2023;9:150.","journal-title":"NPJ Parkinsons Dis"},{"key":"7893_CR180","doi-asserted-by":"crossref","unstructured":"Jiang YQ, Chen QZ, Yang Y, Zang CX, Ma JW, Wang JR, et al. White matter lesions contribute to motor and non-motor disorders in Parkinson\u2019s disease: a critical review. Geroscience. 2025;47:591\u2013609.","DOI":"10.1007\/s11357-024-01428-1"},{"key":"7893_CR181","doi-asserted-by":"crossref","unstructured":"Dehestani M, Kozareva V, Blauwendraat C, Fraenkel E, Gasser T, Bansal V. Transcriptomic changes in oligodendrocytes and precursor cells predicts clinical outcomes of Parkinson\u2019s disease. Mol Brain. 2024;17:56.","DOI":"10.1186\/s13041-024-01128-z"},{"key":"7893_CR182","doi-asserted-by":"crossref","unstructured":"Khan E, Hasan I, Haque ME. Parkinson\u2019s disease: exploring different animal model systems. Int. J. Mol. Sci. 2023;24:9088.","DOI":"10.3390\/ijms24109088"},{"key":"7893_CR183","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1089\/zeb.2018.1712","volume":"16","author":"L van Steijn","year":"2019","unstructured":"van Steijn L, Verbeek FJ, Spaink HP, Merks RMH. Predicting metabolism from gene expression in an improved whole-genome metabolic network model of Danio rerio. Zebrafish. 2019;16:348\u201362.","journal-title":"Zebrafish"},{"key":"7893_CR184","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1038\/aps.2017.49","volume":"38","author":"QS Zhang","year":"2017","unstructured":"Zhang QS, Heng Y, Mou Z, Huang JY, Yuan YH, Chen NH. Reassessment of subacute MPTP-treated mice as animal model of Parkinson\u2019s disease. Acta Pharm Sin. 2017;38:1317\u201328.","journal-title":"Acta Pharm Sin"},{"key":"7893_CR185","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/nprot.2006.342","volume":"2","author":"V Jackson-Lewis","year":"2007","unstructured":"Jackson-Lewis V, Przedborski S. Protocol for the MPTP mouse model of Parkinson\u2019s disease. Nat Protoc. 2007;2:141\u201351.","journal-title":"Nat Protoc"},{"key":"7893_CR186","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/1055-8330(95)90015-2","volume":"4","author":"V Jackson-Lewis","year":"1995","unstructured":"Jackson-Lewis V, Jakowec M, Burke RE, Przedborski S. Time course and morphology of dopaminergic neuronal death caused by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Neurodegeneration. 1995;4:257\u201369.","journal-title":"Neurodegeneration"},{"key":"7893_CR187","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1007\/s00702-007-0790-9","volume":"114","author":"S Takagi","year":"2007","unstructured":"Takagi S, Hayakawa N, Kimoto H, Kato H, Araki T. Damage to oligodendrocytes in the striatum after MPTP neurotoxicity in mice. J Neural Transm (Vienna). 2007;114:1553\u20137.","journal-title":"J Neural Transm (Vienna)"},{"key":"7893_CR188","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/BF03033565","volume":"11","author":"N Simola","year":"2007","unstructured":"Simola N, Morelli M, Carta AR. The 6-hydroxydopamine model of Parkinson\u2019s disease. Neurotox Res. 2007;11:151\u201367.","journal-title":"Neurotox Res"},{"key":"7893_CR189","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/0006-8993(70)90187-3","volume":"24","author":"U Ungerstedt","year":"1970","unstructured":"Ungerstedt U, Arbuthnott GW. Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system. Brain Res. 1970;24:485\u201393.","journal-title":"Brain Res"},{"key":"7893_CR190","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1679\/aohc.45.275","volume":"45","author":"K Imamoto","year":"1982","unstructured":"Imamoto K. Effects of neonatal administrations of 6-OHDA on brain development. III. Myelin degeneration in the mesencephalic tract of the trigeminal nerve. Arch Histol Jpn. 1982;45:275\u201384.","journal-title":"Arch Histol Jpn"},{"key":"7893_CR191","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/scrt124","volume":"3","author":"MM Worlitzer","year":"2012","unstructured":"Worlitzer MM, Bunk EC, Hemmer K, Schwamborn JC. Anti-inflammatory treatment induced regenerative oligodendrogenesis in parkinsonian mice. Stem Cell Res Ther. 2012;3:33.","journal-title":"Stem Cell Res Ther"},{"key":"7893_CR192","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s00441-004-0938-y","volume":"318","author":"A Schober","year":"2004","unstructured":"Schober A. Classic toxin-induced animal models of Parkinson\u2019s disease: 6-OHDA and MPTP. Cell Tissue Res. 2004;318:215\u201324.","journal-title":"Cell Tissue Res"},{"key":"7893_CR193","doi-asserted-by":"publisher","DOI":"10.1017\/S1462399409001148","volume":"11","author":"T Gasser","year":"2009","unstructured":"Gasser T. Molecular pathogenesis of Parkinson disease: insights from genetic studies. Expert Rev Mol Med. 2009;11:e22.","journal-title":"Expert Rev Mol Med"},{"key":"7893_CR194","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/s41531-024-00660-y","volume":"10","author":"N Pena","year":"2024","unstructured":"Pena N, Richbourg T, Gonzalez-Hunt CP, Qi R, Wren P, Barlow C, et al. G2019S selective LRRK2 kinase inhibitor abrogates mitochondrial DNA damage. NPJ Parkinsons Dis. 2024;10:49.","journal-title":"NPJ Parkinsons Dis"},{"key":"7893_CR195","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/s40478-023-01704-9","volume":"11","author":"V Singh","year":"2023","unstructured":"Singh V, Menard MA, Serrano GE, Beach TG, Zhao HT, Riley-DiPaolo A, et al. Cellular and subcellular localization of Rab10 and phospho-T73 Rab10 in the mouse and human brain. Acta Neuropathol Commun. 2023;11:201.","journal-title":"Acta Neuropathol Commun"},{"key":"7893_CR196","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1007\/s10571-017-0465-5","volume":"37","author":"ZH Zhang","year":"2017","unstructured":"Zhang ZH, Zhao WQ, Ma FF, Zhang H, Xu XH. Rab10 disruption results in delayed OPC maturation. Cell Mol Neurobiol. 2017;37:1303\u201310.","journal-title":"Cell Mol Neurobiol"},{"key":"7893_CR197","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/S0896-6273(02)00682-7","volume":"34","author":"BI Giasson","year":"2002","unstructured":"Giasson BI, Duda JE, Quinn SM, Zhang B, Trojanowski JQ, Lee VM. Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein. Neuron. 2002;34:521\u201333.","journal-title":"Neuron"},{"key":"7893_CR198","doi-asserted-by":"crossref","unstructured":"Lee MK, Stirling W, Xu Y, Xu X, Qui D, Mandir AS, et al. Human alpha-synuclein-harboring familial Parkinson\u2019s disease-linked Ala-53 -> Thr mutation causes neurodegenerative disease with alpha-synuclein aggregation in transgenic mice. Proc Natl Acad Sci USA 2002, 99: 8968\u201373.","DOI":"10.1073\/pnas.132197599"},{"key":"7893_CR199","unstructured":"Konnova EA, Swanberg M. Animal Models of Parkinson\u2019s Disease. In: Stoker TB, Greenland JC (eds). Parkinson\u2019s Disease: Pathogenesis and Clinical Aspects. Codon Publications Copyright: The Authors.: Brisbane (AU), (2018)."},{"key":"7893_CR200","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1089\/crispr.2021.0025","volume":"5","author":"HH Yoon","year":"2022","unstructured":"Yoon HH, Ye S, Lim S, Jo A, Lee H, Hong F, et al. CRISPR-Cas9 gene editing protects from the A53T-SNCA overexpression-induced pathology of Parkinson\u2019s Disease in vivo. Crispr j. 2022;5:95\u2013108.","journal-title":"Crispr j"},{"key":"7893_CR201","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s40478-017-0439-3","volume":"5","author":"J Grigoletto","year":"2017","unstructured":"Grigoletto J, Puka\u00df K, Gamliel A, Davidi D, Katz-Brull R, Richter-Landsberg C, et al. Higher levels of myelin phospholipids in brains of neuronal \u03b1-Synuclein transgenic mice precede myelin loss. Acta Neuropathol Commun. 2017;5:37.","journal-title":"Acta Neuropathol Commun"},{"key":"7893_CR202","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/S0002-9440(10)62307-3","volume":"166","author":"N Stefanova","year":"2005","unstructured":"Stefanova N, Reindl M, Neumann M, Haass C, Poewe W, Kahle PJ, et al. Oxidative stress in transgenic mice with oligodendroglial alpha-synuclein overexpression replicates the characteristic neuropathology of multiple system atrophy. Am J Pathol. 2005;166:869\u201376.","journal-title":"Am J Pathol"},{"key":"7893_CR203","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.expneurol.2010.05.008","volume":"224","author":"S Stemberger","year":"2010","unstructured":"Stemberger S, Poewe W, Wenning GK, Stefanova N. Targeted overexpression of human alpha-synuclein in oligodendroglia induces lesions linked to MSA-like progressive autonomic failure. Exp Neurol. 2010;224:459\u201364.","journal-title":"Exp Neurol"},{"key":"7893_CR204","doi-asserted-by":"publisher","first-page":"6236","DOI":"10.1523\/JNEUROSCI.0567-10.2010","volume":"30","author":"K Ubhi","year":"2010","unstructured":"Ubhi K, Rockenstein E, Mante M, Inglis C, Adame A, Patrick C, et al. Neurodegeneration in a transgenic mouse model of multiple system atrophy is associated with altered expression of oligodendroglial-derived neurotrophic factors. J Neurosci. 2010;30:6236\u201346.","journal-title":"J Neurosci"},{"key":"7893_CR205","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1007\/s00401-011-0833-z","volume":"121","author":"L Fellner","year":"2011","unstructured":"Fellner L, Jellinger KA, Wenning GK, Stefanova N. Glial dysfunction in the pathogenesis of \u03b1-synucleinopathies: emerging concepts. Acta Neuropathol. 2011;121:675\u201393.","journal-title":"Acta Neuropathol"},{"key":"7893_CR206","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nature20413","volume":"539","author":"JP Taylor","year":"2016","unstructured":"Taylor JP, Brown RH Jr, Cleveland DW. Decoding ALS: from genes to mechanism. Nature. 2016;539:197\u2013206.","journal-title":"Nature"},{"key":"7893_CR207","doi-asserted-by":"publisher","first-page":"4379","DOI":"10.3892\/mmr.2017.7186","volume":"16","author":"T Zhou","year":"2017","unstructured":"Zhou T, Ahmad TK, Gozda K, Truong J, Kong J, Namaka M. Implications of white matter damage in amyotrophic lateral sclerosis (Review). Mol Med Rep. 2017;16:4379\u201392.","journal-title":"Mol Med Rep"},{"key":"7893_CR208","first-page":"87","volume":"34","author":"J Rafa\u0142owska","year":"1996","unstructured":"Rafa\u0142owska J, Dziewulska D. White matter injury in amyotrophic lateral sclerosis (ALS). Folia Neuropathol. 1996;34:87\u201391.","journal-title":"Folia Neuropathol"},{"key":"7893_CR209","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2024.103633","volume":"43","author":"HP M\u00fcller","year":"2024","unstructured":"M\u00fcller HP, Abrahao A, Beaulieu C, Benatar M, Dionne A, Genge A, et al. Temporal and spatial progression of microstructural cerebral degeneration in ALS: A multicentre longitudinal diffusion tensor imaging study. Neuroimage Clin. 2024;43:103633.","journal-title":"Neuroimage Clin"},{"key":"7893_CR210","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2020.102516","volume":"28","author":"L Cheng","year":"2020","unstructured":"Cheng L, Tang X, Luo C, Liu D, Zhang Y, Zhang J. Fiber-specific white matter reductions in amyotrophic lateral sclerosis. Neuroimage Clin. 2020;28:102516.","journal-title":"Neuroimage Clin"},{"key":"7893_CR211","doi-asserted-by":"publisher","first-page":"102863","DOI":"10.1016\/j.nicl.2021.102863","volume":"32","author":"HJ Chen","year":"2021","unstructured":"Chen HJ, Zhan C, Cai LM, Lin JH, Zhou MX, Zou ZY, et al. White matter microstructural impairments in amyotrophic lateral sclerosis: A mean apparent propagator MRI study. Neuroimage Clin. 2021;32:102863.","journal-title":"Neuroimage Clin"},{"key":"7893_CR212","doi-asserted-by":"crossref","unstructured":"Traiffort E, Morisset-Lopez S, Moussaed M, Zahaf A. Defective Oligodendroglial Lineage and Demyelination in Amyotrophic Lateral Sclerosis. Int J Mol Sci. 2021;22:3426.","DOI":"10.3390\/ijms22073426"},{"key":"7893_CR213","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s00401-023-02666-x","volume":"147","author":"Y Zhu","year":"2024","unstructured":"Zhu Y, Burg T, Neyrinck K, Vervliet T, Nami F, Vervoort E, et al. Disruption of MAM integrity in mutant FUS oligodendroglial progenitors from hiPSCs. Acta Neuropathol. 2024;147:6.","journal-title":"Acta Neuropathol"},{"key":"7893_CR214","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/364362c0","volume":"364","author":"DR Rosen","year":"1993","unstructured":"Rosen DR. Mutations in Cu\/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993;364:362.","journal-title":"Nature"},{"key":"7893_CR215","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s40035-016-0050-8","volume":"5","author":"HF Li","year":"2016","unstructured":"Li HF, Wu ZY. Genotype-phenotype correlations of amyotrophic lateral sclerosis. Transl Neurodegener. 2016;5:3.","journal-title":"Transl Neurodegener"},{"key":"7893_CR216","doi-asserted-by":"crossref","unstructured":"De Giorgio F, Maduro C, Fisher EMC, Acevedo-Arozena A. Transgenic and physiological mouse models give insights into different aspects of amyotrophic lateral sclerosis. Dis Model Mech. 2019;12:dmm037424.","DOI":"10.1242\/dmm.037424"},{"key":"7893_CR217","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.neuron.2011.09.010","volume":"72","author":"AE Renton","year":"2011","unstructured":"Renton AE, Majounie E, Waite A, Sim\u00f3n-S\u00e1nchez J, Rollinson S, Gibbs JR, et al. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron. 2011;72:257\u201368.","journal-title":"Neuron"},{"key":"7893_CR218","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1126\/science.1165942","volume":"323","author":"C Vance","year":"2009","unstructured":"Vance C, Rogelj B, Hortob\u00e1gyi T, De Vos KJ, Nishimura AL, Sreedharan J, et al. Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science. 2009;323:1208\u201311.","journal-title":"Science"},{"key":"7893_CR219","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1007\/s00439-017-1830-7","volume":"136","author":"K Kapeli","year":"2017","unstructured":"Kapeli K, Martinez FJ, Yeo GW. Genetic mutations in RNA-binding proteins and their roles in ALS. Hum Genet. 2017;136:1193\u2013214.","journal-title":"Hum Genet"},{"key":"7893_CR220","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s40035-023-00377-7","volume":"12","author":"L Zhu","year":"2023","unstructured":"Zhu L, Li S, Li XJ, Yin P. Pathological insights from amyotrophic lateral sclerosis animal models: comparisons, limitations, and challenges. Transl Neurodegener. 2023;12:46.","journal-title":"Transl Neurodegener"},{"key":"7893_CR221","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1002\/glia.23825","volume":"68","author":"KM Guzman","year":"2020","unstructured":"Guzman KM, Brink LE, Rodriguez-Bey G, Bodnar RJ, Kuang L, Xing B, et al. Conditional depletion of Fus in oligodendrocytes leads to motor hyperactivity and increased myelin deposition associated with Akt and cholesterol activation. Glia. 2020;68:2040\u201356.","journal-title":"Glia"},{"key":"7893_CR222","doi-asserted-by":"publisher","first-page":"E10941","DOI":"10.1073\/pnas.1809821115","volume":"115","author":"J Wang","year":"2018","unstructured":"Wang J, Ho WY, Lim K, Feng J, Tucker-Kellogg G, Nave KA, et al. Cell-autonomous requirement of TDP-43, an ALS\/FTD signature protein, for oligodendrocyte survival and myelination. Proc Natl Acad Sci USA. 2018;115:E10941\u2013e10950.","journal-title":"Proc Natl Acad Sci USA"},{"key":"7893_CR223","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1126\/science.8209258","volume":"264","author":"ME Gurney","year":"1994","unstructured":"Gurney ME, Pu H, Chiu AY, Dal Canto MC, Polchow CY, Alexander DD, et al. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science. 1994;264:1772\u20135.","journal-title":"Science"},{"key":"7893_CR224","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/nrneurol.2016.182","volume":"13","author":"A Al-Chalabi","year":"2017","unstructured":"Al-Chalabi A, van den Berg LH, Veldink J. Gene discovery in amyotrophic lateral sclerosis: implications for clinical management. Nat Rev Neurol. 2017;13:96\u2013104.","journal-title":"Nat Rev Neurol"},{"key":"7893_CR225","doi-asserted-by":"crossref","unstructured":"Bonfanti E, Bonifacino T, Raffaele S, Milanese M, Morgante E, Bonanno G, et al. Abnormal upregulation of GPR17 receptor contributes to Oligodendrocyte dysfunction in SOD1 G93A Mice. Int J Mol Sci. 2020;21:2395.","DOI":"10.3390\/ijms21072395"},{"key":"7893_CR226","doi-asserted-by":"publisher","first-page":"e94826","DOI":"10.1371\/journal.pone.0094826","volume":"9","author":"G Sanchez","year":"2014","unstructured":"Sanchez G, Varaschin RK, B\u00fceler H, Marcogliese PC, Park DS, Trudeau LE. Unaltered striatal dopamine release levels in young Parkin knockout, Pink1 knockout, DJ-1 knockout and LRRK2 R1441G transgenic mice. PLoS One. 2014;9:e94826.","journal-title":"PLoS One"},{"key":"7893_CR227","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1136\/svn-2023-002791","volume":"9","author":"LJ Zhang","year":"2024","unstructured":"Zhang LJ, Tian DC, Yang L, Shi K, Liu Y, Wang Y, et al. White matter disease derived from vascular and demyelinating origins. Stroke Vasc Neurol. 2024;9:344\u201350.","journal-title":"Stroke Vasc Neurol"},{"key":"7893_CR228","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.pneurobio.2016.04.005","volume":"141","author":"Y Wang","year":"2016","unstructured":"Wang Y, Liu G, Hong D, Chen F, Ji X, Cao G. White matter injury in ischemic stroke. Prog Neurobiol. 2016;141:45\u201360.","journal-title":"Prog Neurobiol"},{"key":"7893_CR229","doi-asserted-by":"publisher","first-page":"e91426","DOI":"10.1371\/journal.pone.0091426","volume":"9","author":"CY Cheng","year":"2014","unstructured":"Cheng CY, Lin JG, Tang NY, Kao ST, Hsieh CL. Electroacupuncture-like stimulation at the Baihui (GV20) and Dazhui (GV14) acupoints protects rats against subacute-phase cerebral ischemia-reperfusion injuries by reducing S100B-mediated neurotoxicity. PLoS One. 2014;9:e91426.","journal-title":"PLoS One"},{"key":"7893_CR230","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.nbd.2018.07.023","volume":"126","author":"MA Marin","year":"2019","unstructured":"Marin MA, Carmichael ST. Mechanisms of demyelination and remyelination in the young and aged brain following white matter stroke. Neurobiol Dis. 2019;126:5\u201312.","journal-title":"Neurobiol Dis"},{"key":"7893_CR231","doi-asserted-by":"publisher","first-page":"e1298","DOI":"10.1212\/WNL.0000000000007142","volume":"92","author":"MK Georgakis","year":"2019","unstructured":"Georgakis MK, Duering M, Wardlaw JM, Dichgans M. WMH and long-term outcomes in ischemic stroke: A systematic review and meta-analysis. Neurology. 2019;92:e1298\u2013e1308.","journal-title":"Neurology"},{"key":"7893_CR232","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2023.1170675","volume":"14","author":"JD Sokolowski","year":"2023","unstructured":"Sokolowski JD, Soldozy S, Sharifi KA, Norat P, Kearns KN, Liu L, et al. Preclinical models of middle cerebral artery occlusion: new imaging approaches to a classic technique. Front Neurol. 2023;14:1170675.","journal-title":"Front Neurol"},{"key":"7893_CR233","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.1161\/STROKEAHA.117.016689","volume":"48","author":"M Tachibana","year":"2017","unstructured":"Tachibana M, Ago T, Wakisaka Y, Kuroda J, Shijo M, Yoshikawa Y, et al. Early Reperfusion After Brain Ischemia Has Beneficial Effects Beyond Rescuing Neurons. Stroke. 2017;48:2222\u201330.","journal-title":"Stroke"},{"key":"7893_CR234","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-05689-0","volume":"14","author":"J Jia","year":"2023","unstructured":"Jia J, Zheng L, Ye L, Chen J, Shu S, Xu S, et al. CD11c(+) microglia promote white matter repair after ischemic stroke. Cell Death Dis. 2023;14:156.","journal-title":"Cell Death Dis"},{"key":"7893_CR235","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1161\/01.STR.20.1.84","volume":"20","author":"EZ Longa","year":"1989","unstructured":"Longa EZ, Weinstein PR, Carlson S, Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke. 1989;20:84\u201391.","journal-title":"Stroke"},{"key":"7893_CR236","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3389\/fnmol.2016.00131","volume":"9","author":"X Yang","year":"2016","unstructured":"Yang X, Wu Q, Zhang L, Feng L. Inhibition of Histone Deacetylase 3 (HDAC3) mediates ischemic preconditioning and protects Cortical neurons against ischemia in rats. Front Mol Neurosci. 2016;9:131.","journal-title":"Front Mol Neurosci"},{"key":"7893_CR237","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s13105-021-00848-3","volume":"78","author":"X Zhou","year":"2022","unstructured":"Zhou X, Qiao B. Inhibition of HDAC3 and ATXN3 by miR-25 prevents neuronal loss and ameliorates neurological recovery in cerebral stroke experimental rats. J Physiol Biochem. 2022;78:139\u201349.","journal-title":"J Physiol Biochem"},{"key":"7893_CR238","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1177\/0271678X221084410","volume":"42","author":"H Kemps","year":"2022","unstructured":"Kemps H, Dessy C, Dumas L, Sonveaux P, Alders L, Van Broeckhoven J, et al. Extremely low frequency electromagnetic stimulation reduces ischemic stroke volume by improving cerebral collateral blood flow. J Cereb Blood Flow Metab. 2022;42:979\u201396.","journal-title":"J Cereb Blood Flow Metab"},{"key":"7893_CR239","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1093\/brain\/awae029","volume":"147","author":"YJ Cheng","year":"2024","unstructured":"Cheng YJ, Wang F, Feng J, Yu B, Wang B, Gao Q, et al. Prolonged myelin deficits contribute to neuron loss and functional impairments after ischaemic stroke. Brain. 2024;147:1294\u2013311.","journal-title":"Brain"},{"key":"7893_CR240","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12031-020-01733-2","volume":"71","author":"QZ Tuo","year":"2021","unstructured":"Tuo QZ, Zou JJ, Lei P. Rodent models of vascular cognitive impairment. J Mol Neurosci. 2021;71:1\u201312.","journal-title":"J Mol Neurosci"},{"key":"7893_CR241","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jchemneu.2018.04.006","volume":"92","author":"AB Wahul","year":"2018","unstructured":"Wahul AB, Joshi PC, Kumar A, Chakravarty S. Transient global cerebral ischemia differentially affects cortex, striatum and hippocampus in Bilateral Common Carotid Arterial occlusion (BCCAo) mouse model. J Chem Neuroanat. 2018;92:1\u201315.","journal-title":"J Chem Neuroanat"},{"key":"7893_CR242","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1161\/STROKEAHA.115.011679","volume":"47","author":"BR Choi","year":"2016","unstructured":"Choi BR, Kim DH, Back DB, Kang CH, Moon WJ, Han JS, et al. Characterization of white matter injury in a rat model of chronic cerebral hypoperfusion. Stroke. 2016;47:542\u20137.","journal-title":"Stroke"},{"key":"7893_CR243","doi-asserted-by":"publisher","first-page":"86","DOI":"10.3389\/fnagi.2020.00086","volume":"12","author":"J Wang","year":"2020","unstructured":"Wang J, Yang C, Wang H, Li D, Li T, Sun Y, et al. A new rat model of chronic cerebral hypoperfusion resulting in early-stage vascular cognitive impairment. Front Aging Neurosci. 2020;12:86.","journal-title":"Front Aging Neurosci"},{"key":"7893_CR244","doi-asserted-by":"publisher","first-page":"2598","DOI":"10.1161\/01.STR.0000143725.19053.60","volume":"35","author":"M Shibata","year":"2004","unstructured":"Shibata M, Ohtani R, Ihara M, Tomimoto H. White matter lesions and glial activation in a novel mouse model of chronic cerebral hypoperfusion. Stroke. 2004;35:2598\u2013603.","journal-title":"Stroke"},{"key":"7893_CR245","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1177\/0271678X231154597","volume":"43","author":"H Ishikawa","year":"2023","unstructured":"Ishikawa H, Shindo A, Mizutani A, Tomimoto H, Lo EH, Arai K. A brief overview of a mouse model of cerebral hypoperfusion by bilateral carotid artery stenosis. J Cereb Blood Flow Metab. 2023;43:18\u201336.","journal-title":"J Cereb Blood Flow Metab"},{"key":"7893_CR246","volume":"14","author":"M Kakae","year":"2024","unstructured":"Kakae M, Kawashita A, Onogi H, Nakagawa T, Shirakawa H. Bilateral common carotid artery stenosis in mice: a model of chronic cerebral hypoperfusion-induced vascular cognitive impairment. Bio Protoc. 2024;14:e5022.","journal-title":"Bio Protoc"},{"key":"7893_CR247","doi-asserted-by":"crossref","unstructured":"Xie Y, Zhang X, Xu P, Zhao N, Zhao Y, Li Y, et al. Aberrant oligodendroglial LDL receptor orchestrates demyelination in chronic cerebral ischemia. J Clin Invest. 2021;131:e128114.","DOI":"10.1172\/JCI128114"},{"key":"7893_CR248","doi-asserted-by":"crossref","unstructured":"Back DB, Choi BR, Han JS, Kwon KJ, Choi DH, Shin CY, et al. Characterization of Tauopathy in a rat model of post-stroke dementia combining acute infarct and chronic cerebral hypoperfusion. Int J Mol Sci. 2020;21:6929.","DOI":"10.3390\/ijms21186929"},{"key":"7893_CR249","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.629151","volume":"11","author":"LP Westphal","year":"2020","unstructured":"Westphal LP, Schweizer J, Fluri F, De Marchis GM, Christ-Crain M, Luft AR, et al. C-Terminal-Pro-Endothelin-1 Adds Incremental Prognostic Value for Risk Stratification After Ischemic Stroke. Front Neurol. 2020;11:629151.","journal-title":"Front Neurol"},{"key":"7893_CR250","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.bbr.2006.01.014","volume":"169","author":"SB Frost","year":"2006","unstructured":"Frost SB, Barbay S, Mumert ML, Stowe AM, Nudo RJ. An animal model of capsular infarct: endothelin-1 injections in the rat. Behav Brain Res. 2006;169:206\u201311.","journal-title":"Behav Brain Res"},{"key":"7893_CR251","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s00401-017-1667-0","volume":"133","author":"CJ Sommer","year":"2017","unstructured":"Sommer CJ. Ischemic stroke: experimental models and reality. Acta Neuropathol. 2017;133:245\u201361.","journal-title":"Acta Neuropathol"},{"key":"7893_CR252","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1111\/jnc.13262","volume":"135","author":"K Iijima","year":"2015","unstructured":"Iijima K, Kurachi M, Shibasaki K, Naruse M, Puentes S, Imai H, et al. Transplanted microvascular endothelial cells promote oligodendrocyte precursor cell survival in ischemic demyelinating lesions. J Neurochem. 2015;135:539\u201350.","journal-title":"J Neurochem"},{"key":"7893_CR253","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1248\/bpb.b20-00510","volume":"44","author":"K Ohashi","year":"2021","unstructured":"Ohashi K, Shibasaki K, Nakazawa H, Kunimasa R, Nagayasu K, Shirakawa H, et al. Transient Receptor Potential Melastatin 3 is functionally expressed in Oligodendrocyte precursor cells and is upregulated in ischemic demyelinated lesions. Biol Pharm Bull. 2021;44:181\u20137.","journal-title":"Biol Pharm Bull"},{"key":"7893_CR254","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/978-1-0716-2409-8_5","volume":"2515","author":"M Lui","year":"2022","unstructured":"Lui M, Gouveia A, Lagace D, Wang J. Combination of Endothelin-1 (ET-1) and L-NAME to induce murine focal cortical stroke with persistent sensorimotor deficits. Methods Mol Biol. 2022;2515:75\u201387.","journal-title":"Methods Mol Biol"},{"key":"7893_CR255","doi-asserted-by":"publisher","first-page":"3","DOI":"10.5853\/jos.2016.00864","volume":"19","author":"SJ An","year":"2017","unstructured":"An SJ, Kim TJ, Yoon BW. Epidemiology, risk factors, and clinical features of intracerebral hemorrhage: an update. J Stroke. 2017;19:3\u201310.","journal-title":"J Stroke"},{"key":"7893_CR256","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.emc.2016.06.010","volume":"34","author":"A Morotti","year":"2016","unstructured":"Morotti A, Goldstein JN. Diagnosis and management of acute intracerebral hemorrhage. Emerg Med Clin North Am. 2016;34:883\u201399.","journal-title":"Emerg Med Clin North Am"},{"key":"7893_CR257","doi-asserted-by":"publisher","first-page":"e282","DOI":"10.1161\/STR.0000000000000407","volume":"53","author":"SM Greenberg","year":"2022","unstructured":"Greenberg SM, Ziai WC, Cordonnier C, Dowlatshahi D, Francis B, Goldstein JN, et al. 2022 Guideline for the Management of Patients With Spontaneous Intracerebral Hemorrhage: A Guideline From the American Heart Association\/American Stroke Association. Stroke. 2022;53:e282\u2013e361.","journal-title":"Stroke"},{"key":"7893_CR258","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1161\/STROKEAHA.110.596718","volume":"42","author":"J Aronowski","year":"2011","unstructured":"Aronowski J, Zhao X. Molecular pathophysiology of cerebral hemorrhage: secondary brain injury. Stroke. 2011;42:1781\u20136.","journal-title":"Stroke"},{"key":"7893_CR259","doi-asserted-by":"publisher","first-page":"e0215952","DOI":"10.1371\/journal.pone.0215952","volume":"14","author":"CM Wilkinson","year":"2019","unstructured":"Wilkinson CM, Brar PS, Balay CJ, Colbourne F. Glibenclamide, a Sur1-Trpm4 antagonist, does not improve outcome after collagenase-induced intracerebral hemorrhage. PLoS One. 2019;14:e0215952.","journal-title":"PLoS One"},{"key":"7893_CR260","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuroscience.2023.01.011","volume":"513","author":"J Fang","year":"2023","unstructured":"Fang J, Song F, Chang C, Yao M. Intracerebral hemorrhage models and behavioral tests in rodents. Neuroscience. 2023;513:1\u201313.","journal-title":"Neuroscience"},{"key":"7893_CR261","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3171\/jns.1994.81.1.0093","volume":"81","author":"GY Yang","year":"1994","unstructured":"Yang GY, Betz AL, Chenevert TL, Brunberg JA, Hoff JT. Experimental intracerebral hemorrhage: relationship between brain edema, blood flow, and blood-brain barrier permeability in rats. J Neurosurg. 1994;81:93\u2013102.","journal-title":"J Neurosurg"},{"key":"7893_CR262","doi-asserted-by":"publisher","first-page":"4999","DOI":"10.1007\/s12035-021-02468-w","volume":"58","author":"R Deng","year":"2021","unstructured":"Deng R, Wang W, Xu X, Ding J, Wang J, Yang S, et al. Loss of MIC60 aggravates neuronal death by inducing mitochondrial dysfunction in a rat model of intracerebral hemorrhage. Mol Neurobiol. 2021;58:4999\u20135013.","journal-title":"Mol Neurobiol"},{"key":"7893_CR263","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-04712-0","volume":"13","author":"D Shen","year":"2022","unstructured":"Shen D, Wu W, Liu J, Lan T, Xiao Z, Gai K, et al. Ferroptosis in oligodendrocyte progenitor cells mediates white matter injury after hemorrhagic stroke. Cell Death Dis. 2022;13:259.","journal-title":"Cell Death Dis"},{"key":"7893_CR264","first-page":"1750","volume":"18","author":"J Qu","year":"2023","unstructured":"Qu J, Zong HF, Shan Y, Zhang SC, Guan WP, Yang Y, et al. Piezo1 suppression reduces demyelination after intracerebral hemorrhage. Neural Regen Res. 2023;18:1750\u20136.","journal-title":"Neural Regen Res"},{"key":"7893_CR265","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1080\/01616412.1996.11740456","volume":"18","author":"W Deinsberger","year":"1996","unstructured":"Deinsberger W, Vogel J, Kuschinsky W, Auer LM, B\u00f6ker DK. Experimental intracerebral hemorrhage: description of a double injection model in rats. Neurol Res. 1996;18:475\u20137.","journal-title":"Neurol Res"},{"key":"7893_CR266","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.brainres.2006.01.045","volume":"1078","author":"B Ma","year":"2006","unstructured":"Ma B, Zhang J. Nimodipine treatment to assess a modified mouse model of intracerebral hemorrhage. Brain Res. 2006;1078:182\u20138.","journal-title":"Brain Res"},{"key":"7893_CR267","doi-asserted-by":"publisher","first-page":"3384","DOI":"10.1161\/STROKEAHA.108.544395","volume":"40","author":"K Karki","year":"2009","unstructured":"Karki K, Knight RA, Han Y, Yang D, Zhang J, Ledbetter KA, et al. Simvastatin and atorvastatin improve neurological outcome after experimental intracerebral hemorrhage. Stroke. 2009;40:3384\u20139.","journal-title":"Stroke"},{"key":"7893_CR268","doi-asserted-by":"crossref","unstructured":"Lei B, Sheng H, Wang H, Lascola CD, Warner DS, Laskowitz DT, et al. Intrastriatal injection of autologous blood or clostridial collagenase as murine models of intracerebral hemorrhage. J Vis Exp. 2014;89:51439.","DOI":"10.3791\/51439"},{"key":"7893_CR269","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1161\/01.STR.21.5.801","volume":"21","author":"GA Rosenberg","year":"1990","unstructured":"Rosenberg GA, Mun-Bryce S, Wesley M, Kornfeld M. Collagenase-induced intracerebral hemorrhage in rats. Stroke. 1990;21:801\u20137.","journal-title":"Stroke"},{"key":"7893_CR270","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/0304-3940(93)90927-D","volume":"160","author":"GA Rosenberg","year":"1993","unstructured":"Rosenberg GA, Estrada E, Kelley RO, Kornfeld M. Bacterial collagenase disrupts extracellular matrix and opens blood-brain barrier in rat. Neurosci Lett. 1993;160:117\u20139.","journal-title":"Neurosci Lett"},{"key":"7893_CR271","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1007\/s12975-015-0445-3","volume":"7","author":"MJ Joseph","year":"2016","unstructured":"Joseph MJ, Caliaperumal J, Schlichter LC. After intracerebral hemorrhage, oligodendrocyte precursors proliferate and differentiate inside white-matter tracts in the rat striatum. Transl Stroke Res. 2016;7:192\u2013208.","journal-title":"Transl Stroke Res"},{"key":"7893_CR272","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s12028-007-9030-2","volume":"9","author":"ML James","year":"2008","unstructured":"James ML, Warner DS, Laskowitz DT. Preclinical models of intracerebral hemorrhage: a translational perspective. Neurocrit Care. 2008;9:139\u201352.","journal-title":"Neurocrit Care"},{"key":"7893_CR273","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S1042-3680(02)00006-2","volume":"13","author":"N Andaluz","year":"2002","unstructured":"Andaluz N, Zuccarello M, Wagner KR. Experimental animal models of intracerebral hemorrhage. Neurosurg Clin N Am. 2002;13:385\u201393.","journal-title":"Neurosurg Clin N Am"},{"key":"7893_CR274","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1212\/WNL.48.4.921","volume":"48","author":"GA Rosenberg","year":"1997","unstructured":"Rosenberg GA, Navratil M. Metalloproteinase inhibition blocks edema in intracerebral hemorrhage in the rat. Neurology. 1997;48:921\u20136.","journal-title":"Neurology"},{"key":"7893_CR275","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1111\/j.1747-4949.2011.00659.x","volume":"6","author":"EL Bailey","year":"2011","unstructured":"Bailey EL, Smith C, Sudlow CL, Wardlaw JM. Is the spontaneously hypertensive stroke prone rat a pertinent model of sub cortical ischemic stroke? A systematic review. Int J Stroke. 2011;6:434\u201344.","journal-title":"Int J Stroke"},{"key":"7893_CR276","first-page":"S21","volume":"4","author":"K Okamoto","year":"1986","unstructured":"Okamoto K, Yamamoto K, Morita N, Ohta Y, Chikugo T, Higashizawa T, et al. Establishment and use of the M strain of stroke-prone spontaneously hypertensive rat. J Hypertens Suppl. 1986;4:S21\u201324.","journal-title":"J Hypertens Suppl"},{"key":"7893_CR277","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/s12975-016-0486-2","volume":"7","author":"Y Yang","year":"2016","unstructured":"Yang Y, Kimura-Ohba S, Thompson J, Rosenberg GA. Rodent models of vascular cognitive impairment. Transl Stroke Res. 2016;7:407\u201314.","journal-title":"Transl Stroke Res"},{"key":"7893_CR278","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/jcbfm.2015.172","volume":"36","author":"GA Rosenberg","year":"2016","unstructured":"Rosenberg GA, Wallin A, Wardlaw JM, Markus HS, Montaner J, Wolfson L, et al. Consensus statement for diagnosis of subcortical small vessel disease. J Cereb Blood Flow Metab. 2016;36:6\u201325.","journal-title":"J Cereb Blood Flow Metab"},{"key":"7893_CR279","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1097\/HJH.0b013e3280464dc8","volume":"25","author":"T Ishizuka","year":"2007","unstructured":"Ishizuka T, Niwa A, Tabuchi M, Nagatani Y, Ooshima K, Higashino H. Involvement of thromboxane A2 receptor in the cerebrovascular damage of salt-loaded, stroke-prone rats. J Hypertens. 2007;25:861\u201370.","journal-title":"J Hypertens"},{"key":"7893_CR280","doi-asserted-by":"publisher","first-page":"3779","DOI":"10.1007\/s11357-024-01074-7","volume":"46","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Sheikh AM, Tabassum S, Iwasa K, Shibly AZ, Zhou X, et al. Effect of high-fat diet on cerebral pathological changes of cerebral small vessel disease in SHR\/SP rats. Geroscience. 2024;46:3779\u20133800.","journal-title":"Geroscience"},{"key":"7893_CR281","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1002\/jnr.20219","volume":"78","author":"L Sironi","year":"2004","unstructured":"Sironi L, Guerrini U, Tremoli E, Miller I, Gelosa P, Lascialfari A, et al. Analysis of pathological events at the onset of brain damage in stroke-prone rats: a proteomics and magnetic resonance imaging approach. J Neurosci Res. 2004;78:115\u201322.","journal-title":"J Neurosci Res"},{"key":"7893_CR282","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.jpeds.2010.06.016","volume":"157","author":"AR Synnes","year":"2010","unstructured":"Synnes AR, Anson S, Arkesteijn A, Butt A, Grunau RE, Rogers M, et al. School entry age outcomes for infants with birth weight \u2264800 grams. J Pediatr. 2010;157:989\u2013994.e981.","journal-title":"J Pediatr"},{"key":"7893_CR283","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S0378-3782(98)00037-1","volume":"53","author":"JM Perlman","year":"1998","unstructured":"Perlman JM. White matter injury in the preterm infant: an important determination of abnormal neurodevelopment outcome. Early Hum Dev. 1998;53:99\u2013120.","journal-title":"Early Hum Dev"},{"key":"7893_CR284","doi-asserted-by":"publisher","DOI":"10.1016\/j.semperi.2021.151469","volume":"45","author":"M Guillot","year":"2021","unstructured":"Guillot M, Miller SP. The dimensions of white matter injury in preterm neonates. Semin Perinatol. 2021;45:151469.","journal-title":"Semin Perinatol"},{"key":"7893_CR285","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1002\/ana.410090206","volume":"9","author":"JE Rice 3rd","year":"1981","unstructured":"Rice JE 3rd, Vannucci RC, Brierley JB. The influence of immaturity on hypoxic-ischemic brain damage in the rat. Ann Neurol. 1981;9:131\u201341.","journal-title":"Ann Neurol"},{"key":"7893_CR286","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1002\/(SICI)1097-4547(19990115)55:2<158::AID-JNR3>3.0.CO;2-1","volume":"55","author":"RC Vannucci","year":"1999","unstructured":"Vannucci RC, Connor JR, Mauger DT, Palmer C, Smith MB, Towfighi J, et al. Rat model of perinatal hypoxic-ischemic brain damage. J Neurosci Res. 1999;55:158\u201363.","journal-title":"J Neurosci Res"},{"key":"7893_CR287","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1159\/000523990","volume":"44","author":"SJ Vannucci","year":"2022","unstructured":"Vannucci SJ, Back SA. The Vannucci model of hypoxic-ischemic injury in the neonatal rodent: 40 years later. Dev Neurosci. 2022;44:186\u201393.","journal-title":"Dev Neurosci"},{"key":"7893_CR288","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.brainres.2003.08.058","volume":"993","author":"A Stadlin","year":"2003","unstructured":"Stadlin A, James A, Fiscus R, Wong YF, Rogers M, Haines C. Development of a postnatal 3-day-old rat model of mild hypoxic-ischemic brain injury. Brain Res. 2003;993:101\u201310.","journal-title":"Brain Res"},{"key":"7893_CR289","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2022.136994","volume":"793","author":"T Gao","year":"2023","unstructured":"Gao T, Qian T, Wang T, Su Y, Qiu H, Tang W, et al. T0901317, a liver X receptor agonist, ameliorates perinatal white matter injury induced by ischemia and hypoxia in neonatal rats. Neurosci Lett. 2023;793:136994.","journal-title":"Neurosci Lett"},{"key":"7893_CR290","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.expneurol.2015.03.026","volume":"269","author":"YP Deng","year":"2015","unstructured":"Deng YP, Sun Y, Hu L, Li ZH, Xu QM, Pei YL, et al. Chondroitin sulfate proteoglycans impede myelination by oligodendrocytes after perinatal white matter injury. Exp Neurol. 2015;269:213\u201323.","journal-title":"Exp Neurol"},{"key":"7893_CR291","doi-asserted-by":"crossref","unstructured":"Renz P, Schoeberlein A, Haesler V, Maragkou T, Surbek D, Brosius Lutz A. A novel murine multi-hit model of perinatal acute diffuse white matter injury recapitulates major features of human disease. Biomedicines. 2022;10:2810.","DOI":"10.3390\/biomedicines10112810"},{"key":"7893_CR292","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-05483-4","volume":"13","author":"AL Schang","year":"2022","unstructured":"Schang AL, Van Steenwinckel J, Ioannidou ZS, Lipecki J, Rich-Griffin C, Woolley-Allen K, et al. Epigenetic priming of immune\/inflammatory pathways activation and abnormal activity of cell cycle pathway in a perinatal model of white matter injury. Cell Death Dis. 2022;13:1038.","journal-title":"Cell Death Dis"},{"key":"7893_CR293","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00422-w","volume":"8","author":"ML Krishnan","year":"2017","unstructured":"Krishnan ML, Van Steenwinckel J, Schang AL, Yan J, Arnadottir J, Le Charpentier T, et al. Integrative genomics of microglia implicates DLG4 (PSD95) in the white matter development of preterm infants. Nat Commun. 2017;8:428.","journal-title":"Nat Commun"},{"key":"7893_CR294","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1002\/ana.22489","volume":"70","author":"G Favrais","year":"2011","unstructured":"Favrais G, van de Looij Y, Fleiss B, Ramanantsoa N, Bonnin P, Stoltenburg-Didinger G, et al. Systemic inflammation disrupts the developmental program of white matter. Ann Neurol. 2011;70:550\u201365.","journal-title":"Ann Neurol"},{"key":"7893_CR295","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/nrn3407","volume":"14","author":"Y Xiong","year":"2013","unstructured":"Xiong Y, Mahmood A, Chopp M. Animal models of traumatic brain injury. Nat Rev Neurosci. 2013;14:128\u201342.","journal-title":"Nat Rev Neurosci"},{"key":"7893_CR296","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1007\/s13365-023-01164-w","volume":"29","author":"A Rocchi","year":"2023","unstructured":"Rocchi A, Sariyer IK, Berger JR. Revisiting JC virus and progressive multifocal leukoencephalopathy. J Neurovirol. 2023;29:524\u201337.","journal-title":"J Neurovirol"},{"key":"7893_CR297","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-017-0934-2","volume":"14","author":"X Xu","year":"2017","unstructured":"Xu X, Gao W, Cheng S, Yin D, Li F, Wu Y, et al. Anti-inflammatory and immunomodulatory mechanisms of atorvastatin in a murine model of traumatic brain injury. J Neuroinflammation. 2017;14:167.","journal-title":"J Neuroinflammation"},{"key":"7893_CR298","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.2174\/1570159X15666170613083606","volume":"16","author":"P Kaur","year":"2018","unstructured":"Kaur P, Sharma S. Recent advances in pathophysiology of traumatic brain injury. Curr Neuropharmacol. 2018;16:1224\u201338.","journal-title":"Curr Neuropharmacol"},{"key":"7893_CR299","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1038\/jcbfm.2013.146","volume":"33","author":"G Wang","year":"2013","unstructured":"Wang G, Zhang J, Hu X, Zhang L, Mao L, Jiang X, et al. Microglia\/macrophage polarization dynamics in white matter after traumatic brain injury. J Cereb Blood Flow Metab. 2013;33:1864\u201374.","journal-title":"J Cereb Blood Flow Metab"},{"key":"7893_CR300","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neulet.2012.10.019","volume":"532","author":"CM Atkins","year":"2013","unstructured":"Atkins CM, Cepero ML, Kang Y, Liebl DJ, Dietrich WD. Effects of early rolipram treatment on histopathological outcome after controlled cortical impact injury in mice. Neurosci Lett. 2013;532:1\u20136.","journal-title":"Neurosci Lett"},{"key":"7893_CR301","doi-asserted-by":"publisher","first-page":"997","DOI":"10.4103\/1673-5374.250579","volume":"14","author":"SY Xu","year":"2019","unstructured":"Xu SY, Liu M, Gao Y, Cao Y, Bao JG, Lin YY, et al. Acute histopathological responses and long-term behavioral outcomes in mice with graded controlled cortical impact injury. Neural Regen Res. 2019;14:997\u20131003.","journal-title":"Neural Regen Res"},{"key":"7893_CR302","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.expneurol.2018.07.004","volume":"310","author":"L Siebold","year":"2018","unstructured":"Siebold L, Obenaus A, Goyal R. Criteria to define mild, moderate, and severe traumatic brain injury in the mouse controlled cortical impact model. Exp Neurol. 2018;310:48\u201357.","journal-title":"Exp Neurol"},{"key":"7893_CR303","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-023-02923-6","volume":"20","author":"S Meng","year":"2023","unstructured":"Meng S, Cao H, Huang Y, Shi Z, Li J, Wang Y, et al. ASK1-K716R reduces neuroinflammation and white matter injury via preserving blood-brain barrier integrity after traumatic brain injury. J Neuroinflammation. 2023;20:244.","journal-title":"J Neuroinflammation"},{"key":"7893_CR304","doi-asserted-by":"publisher","first-page":"105744","DOI":"10.1016\/j.neuint.2024.105744","volume":"177","author":"W Zhou","year":"2024","unstructured":"Zhou W, Liang Y, Liao X, Tong L, Du W, Fu W, et al. ISRIB improves white matter injury following TBI by inhibiting NCOA4-mediated ferritinophagy. Neurochem Int. 2024;177:105744.","journal-title":"Neurochem Int"},{"key":"7893_CR305","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/0006-8993(81)90067-6","volume":"211","author":"DM Feeney","year":"1981","unstructured":"Feeney DM, Boyeson MG, Linn RT, Murray HM, Dail WG. Responses to cortical injury: I. Methodology and local effects of contusions in the rat. Brain Res. 1981;211:67\u201377.","journal-title":"Brain Res"},{"key":"7893_CR306","first-page":"134ra160","volume":"4","author":"LE Goldstein","year":"2012","unstructured":"Goldstein LE, Fisher AM, Tagge CA, Zhang XL, Velisek L, Sullivan JA, et al. Chronic traumatic encephalopathy in blast-exposed military veterans and a blast neurotrauma mouse model. Sci Transl Med. 2012;4:134ra160.","journal-title":"Sci Transl Med"},{"key":"7893_CR307","doi-asserted-by":"publisher","first-page":"291","DOI":"10.3171\/jns.1994.80.2.0291","volume":"80","author":"A Marmarou","year":"1994","unstructured":"Marmarou A, Foda MA, van den Brink W, Campbell J, Kita H, Demetriadou K. A new model of diffuse brain injury in rats. Part I: Pathophysiology and biomechanics. J Neurosurg. 1994;80:291\u2013300.","journal-title":"J Neurosurg"},{"key":"7893_CR308","doi-asserted-by":"publisher","first-page":"301","DOI":"10.3171\/jns.1994.80.2.0301","volume":"80","author":"MA Foda","year":"1994","unstructured":"Foda MA, Marmarou A. A new model of diffuse brain injury in rats. Part II: Morphological characterization. J Neurosurg. 1994;80:301\u201313.","journal-title":"J Neurosurg"},{"key":"7893_CR309","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1089\/neu.2009.0968","volume":"26","author":"M Kilbourne","year":"2009","unstructured":"Kilbourne M, Kuehn R, Tosun C, Caridi J, Keledjian K, Bochicchio G, et al. Novel model of frontal impact closed head injury in the rat. J Neurotrauma. 2009;26:2233\u201343.","journal-title":"J Neurotrauma"},{"key":"7893_CR310","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1007\/s004010050421","volume":"91","author":"R Hicks","year":"1996","unstructured":"Hicks R, Soares H, Smith D, McIntosh T. Temporal and spatial characterization of neuronal injury following lateral fluid-percussion brain injury in the rat. Acta Neuropathol. 1996;91:236\u201346.","journal-title":"Acta Neuropathol"},{"key":"7893_CR311","doi-asserted-by":"crossref","unstructured":"Alder J, Fujioka W, Lifshitz J, Crockett DP, Thakker-Varia S. Lateral fluid percussion: model of traumatic brain injury in mice. J Vis Exp. 2011;54:3063.","DOI":"10.3791\/3063"},{"key":"7893_CR312","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1089\/neur.2023.0037","volume":"4","author":"AA Adams","year":"2023","unstructured":"Adams AA, Wood TL, Kim HA. Mature and Myelinating Oligodendrocytes Are Specifically Vulnerable to Mild Fluid Percussion Injury in Mice. Neurotrauma Rep. 2023;4:433\u201346.","journal-title":"Neurotrauma Rep"},{"key":"7893_CR313","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1111\/ejn.12179","volume":"38","author":"J Flygt","year":"2013","unstructured":"Flygt J, Djupsj\u00f6 A, Lenne F, Marklund N. Myelin loss and oligodendrocyte pathology in white matter tracts following traumatic brain injury in the rat. Eur J Neurosci. 2013;38:2153\u201365.","journal-title":"Eur J Neurosci"},{"key":"7893_CR314","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/jcbfm.2009.203","volume":"30","author":"I Cernak","year":"2010","unstructured":"Cernak I, Noble-Haeusslein LJ. Traumatic brain injury: an overview of pathobiology with emphasis on military populations. J Cereb Blood Flow Metab. 2010;30:255\u201366.","journal-title":"J Cereb Blood Flow Metab"},{"key":"7893_CR315","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1089\/neu.2010.1540","volume":"28","author":"RH Garman","year":"2011","unstructured":"Garman RH, Jenkins LW, Switzer RC 3rd, Bauman RA, Tong LC, Swauger PV, et al. Blast exposure in rats with body shielding is characterized primarily by diffuse axonal injury. J Neurotrauma. 2011;28:947\u201359.","journal-title":"J Neurotrauma"},{"key":"7893_CR316","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1089\/neu.2016.4961","volume":"35","author":"TW Sawyer","year":"2018","unstructured":"Sawyer TW, Ritzel DV, Wang Y, Josey T, Villanueva M, Nelson P, et al. Primary blast causes delayed effects without cell death in shell-encased brain cell aggregates. J Neurotrauma. 2018;35:174\u201386.","journal-title":"J Neurotrauma"},{"key":"7893_CR317","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/4671607","volume":"2017","author":"W Zheng","year":"2017","unstructured":"Zheng W, Chen Q, Chen X, Wan L, Qin W, Qi Z, et al. Brain white matter impairment in patients with spinal cord injury. Neural Plast. 2017;2017:4671607.","journal-title":"Neural Plast"},{"key":"7893_CR318","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1007\/s13311-011-0033-5","volume":"8","author":"A Almad","year":"2011","unstructured":"Almad A, Sahinkaya FR, McTigue DM. Oligodendrocyte fate after spinal cord injury. Neurotherapeutics. 2011;8:262\u201373.","journal-title":"Neurotherapeutics"},{"key":"7893_CR319","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.nbd.2003.11.015","volume":"15","author":"C Profyris","year":"2004","unstructured":"Profyris C, Cheema SS, Zang D, Azari MF, Boyle K, Petratos S. Degenerative and regenerative mechanisms governing spinal cord injury. Neurobiol Dis. 2004;15:415\u201336.","journal-title":"Neurobiol Dis"},{"key":"7893_CR320","volume":"2015","author":"N Li","year":"2015","unstructured":"Li N, Leung GK. Oligodendrocyte precursor cells in spinal cord injury: a review and update. Biomed Res Int. 2015;2015:235195.","journal-title":"Biomed Res Int"},{"key":"7893_CR321","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1002\/glia.23706","volume":"68","author":"GJ Duncan","year":"2020","unstructured":"Duncan GJ, Manesh SB, Hilton BJ, Assinck P, Plemel JR, Tetzlaff W. The fate and function of oligodendrocyte progenitor cells after traumatic spinal cord injury. Glia. 2020;68:227\u201345.","journal-title":"Glia"},{"key":"7893_CR322","doi-asserted-by":"crossref","unstructured":"Anjum A, Yazid MD, Fauzi Daud M, Idris J, Ng AMH, Selvi Naicker A, et al. Spinal cord injury: pathophysiology, multimolecular interactions, and underlying recovery mechanisms. Int J Mol Sci. 2020;21:7533.","DOI":"10.3390\/ijms21207533"},{"key":"7893_CR323","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.clinbiomech.2018.03.020","volume":"64","author":"S Mattucci","year":"2019","unstructured":"Mattucci S, Speidel J, Liu J, Kwon BK, Tetzlaff W, Oxland TR. Basic biomechanics of spinal cord injury - How injuries happen in people and how animal models have informed our understanding. Clin Biomech. 2019;64:58\u201368.","journal-title":"Clin Biomech"},{"key":"7893_CR324","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1038\/sc.2016.187","volume":"55","author":"M Sharif-Alhoseini","year":"2017","unstructured":"Sharif-Alhoseini M, Khormali M, Rezaei M, Safdarian M, Hajighadery A, Khalatbari MM, et al. Animal models of spinal cord injury: a systematic review. Spinal Cord. 2017;55:714\u201321.","journal-title":"Spinal Cord"},{"key":"7893_CR325","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1089\/neu.2010.1296","volume":"28","author":"BK Kwon","year":"2011","unstructured":"Kwon BK, Okon EB, Tsai E, Beattie MS, Bresnahan JC, Magnuson DK, et al. A grading system to evaluate objectively the strength of pre-clinical data of acute neuroprotective therapies for clinical translation in spinal cord injury. J Neurotrauma. 2011;28:1525\u201343.","journal-title":"J Neurotrauma"},{"key":"7893_CR326","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1089\/neu.2015.3875","volume":"32","author":"B Khuyagbaatar","year":"2015","unstructured":"Khuyagbaatar B, Kim K, Kim YH. Conversion Equation between the drop height in the New York university impactor and the impact force in the infinite horizon impactor in the contusion spinal cord injury model. J Neurotrauma. 2015;32:1987\u201393.","journal-title":"J Neurotrauma"},{"key":"7893_CR327","doi-asserted-by":"publisher","first-page":"470","DOI":"10.4103\/1673-5374.202923","volume":"12","author":"W Rong","year":"2017","unstructured":"Rong W, Pan YW, Cai X, Song F, Zhao Z, Xiao SH, et al. The mechanism of Naringin-enhanced remyelination after spinal cord injury. Neural Regen Res. 2017;12:470\u20137.","journal-title":"Neural Regen Res"},{"key":"7893_CR328","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-11-71","volume":"11","author":"ZW Li","year":"2014","unstructured":"Li ZW, Li JJ, Wang L, Zhang JP, Wu JJ, Mao XQ, et al. Epidermal growth factor receptor inhibitor ameliorates excessive astrogliosis and improves the regeneration microenvironment and functional recovery in adult rats following spinal cord injury. J Neuroinflammation. 2014;11:71.","journal-title":"J Neuroinflammation"},{"key":"7893_CR329","doi-asserted-by":"publisher","DOI":"10.1515\/tnsci-2022-0287","volume":"14","author":"A Jarragh","year":"2023","unstructured":"Jarragh A, Shuaib A, Al-Khaledi G, Alotaibi F, Al-Sabah S, Masocha W. A custom-made weight-drop impactor to produce consistent spinal cord injury outcomes in a rat model. Transl Neurosci. 2023;14:20220287.","journal-title":"Transl Neurosci"},{"key":"7893_CR330","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1089\/neu.1992.9.129","volume":"9","author":"BT Stokes","year":"1992","unstructured":"Stokes BT. Experimental spinal cord injury: a dynamic and verifiable injury device. J Neurotrauma. 1992;9:129\u201331. discussion 131-124.","journal-title":"J Neurotrauma"},{"key":"7893_CR331","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1055\/s-0032-1315779","volume":"28","author":"W Marcol","year":"2012","unstructured":"Marcol W, Slusarczyk W, Gzik M, Larysz-Brysz M, Bobrowski M, Grynkiewicz-Bylina B, et al. Air gun impactor-a novel model of graded white matter spinal cord injury in rodents. J Reconstr Microsurg. 2012;28:561\u20138.","journal-title":"J Reconstr Microsurg"},{"key":"7893_CR332","doi-asserted-by":"publisher","DOI":"10.1038\/s41597-021-00953-4","volume":"8","author":"BR Kondiles","year":"2021","unstructured":"Kondiles BR, Wei H, Chaboub LS, Horner PJ, Wu JQ, Perlmutter SI. Transcriptome of rat subcortical white matter and spinal cord after spinal injury and cortical stimulation. Sci Data. 2021;8:175.","journal-title":"Sci Data"},{"key":"7893_CR333","doi-asserted-by":"publisher","first-page":"3695","DOI":"10.1073\/pnas.84.11.3695","volume":"84","author":"L Feigenbaum","year":"1987","unstructured":"Feigenbaum L, Khalili K, Major E, Khoury G. Regulation of the host range of human papovavirus JCV. Proc Natl Acad Sci USA. 1987;84:3695\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"7893_CR334","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1126\/science.181.4100.674","volume":"181","author":"DL Walker","year":"1973","unstructured":"Walker DL, Padgett BL, ZuRhein GM, Albert AE, Marsh RF. Human papovavirus (JC): induction of brain tumors in hamsters. Science. 1973;181:674\u20136.","journal-title":"Science"},{"key":"7893_CR335","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1126\/science.211583","volume":"201","author":"WT London","year":"1978","unstructured":"London WT, Houff SA, Madden DL, Fuccillo DA, Gravell M, Wallen WC, et al. Brain tumors in owl monkeys inoculated with a human polyomavirus (JC virus). Science. 1978;201:1246\u20139.","journal-title":"Science"},{"key":"7893_CR336","first-page":"227","volume":"105","author":"WT London","year":"1983","unstructured":"London WT, Houff SA, McKeever PE, Wallen WC, Sever JL, Padgett BL, et al. Viral-induced astrocytomas in squirrel monkeys. Prog Clin Biol Res. 1983;105:227\u201337.","journal-title":"Prog Clin Biol Res"},{"key":"7893_CR337","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/sj.onc.1202278","volume":"18","author":"B Krynska","year":"1999","unstructured":"Krynska B, Otte J, Franks R, Khalili K, Croul S. Human ubiquitous JCV(CY) T-antigen gene induces brain tumors in experimental animals. Oncogene. 1999;18:39\u201346.","journal-title":"Oncogene"},{"key":"7893_CR338","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/nm974","volume":"10","author":"MS Windrem","year":"2004","unstructured":"Windrem MS, Nunes MC, Rashbaum WK, Schwartz TH, Goodman RA, McKhann G 2nd, et al. Fetal and adult human oligodendrocyte progenitor cell isolates myelinate the congenitally dysmyelinated brain. Nat Med. 2004;10:93\u201397.","journal-title":"Nat Med"},{"key":"7893_CR339","doi-asserted-by":"publisher","first-page":"5323","DOI":"10.1172\/JCI76629","volume":"124","author":"Y Kondo","year":"2014","unstructured":"Kondo Y, Windrem MS, Zou L, Chandler-Militello D, Schanz SJ, Auvergne RM, et al. Human glial chimeric mice reveal astrocytic dependence of JC virus infection. J Clin Invest. 2014;124:5323\u201336.","journal-title":"J Clin Invest"},{"key":"7893_CR340","doi-asserted-by":"publisher","first-page":"2869","DOI":"10.1002\/jcp.25047","volume":"230","author":"MK White","year":"2015","unstructured":"White MK, Gordon J, Berger JR, Khalili K. Animal models for progressive multifocal Leukoencephalopathy. J Cell Physiol. 2015;230:2869\u201374.","journal-title":"J Cell Physiol"},{"key":"7893_CR341","doi-asserted-by":"publisher","first-page":"783","DOI":"10.3389\/fimmu.2019.00783","volume":"10","author":"Shwetank","year":"2019","unstructured":"Shwetank, Frost EL, Mockus TE, Ren HM, Toprak M, Lauver MD, et al. PD-1 dynamically regulates inflammation and development of brain-resident memory CD8 T cells during persistent viral Encephalitis. Front Immunol. 2019;10:783.","journal-title":"Front Immunol"},{"key":"7893_CR342","doi-asserted-by":"publisher","first-page":"5744","DOI":"10.1111\/febs.16083","volume":"289","author":"KN Ayers","year":"2022","unstructured":"Ayers KN, Carey SN, Lukacher AE. Understanding polyomavirus CNS disease - a perspective from mouse models. Febs j. 2022;289:5744\u201361.","journal-title":"Febs j"},{"key":"7893_CR343","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s13365-022-01062-7","volume":"28","author":"P Barreras","year":"2022","unstructured":"Barreras P, Pamies D, Monaco MC, Mu\u00f1oz LS, Zhong X, Major EO, et al. A human-derived 3D brain organoid model to study JC virus infection. J Neurovirol. 2022;28:17\u201326.","journal-title":"J Neurovirol"},{"key":"7893_CR344","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/B978-0-443-19102-2.00032-6","volume":"210","author":"EM Hol","year":"2025","unstructured":"Hol EM, Dykstra W, Chevalier J, Cuadrado E, Bugiani M, Aronica E, et al. Neuroglia in leukodystrophies. Handb Clin Neurol. 2025;210:159\u201375.","journal-title":"Handb Clin Neurol"},{"key":"7893_CR345","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1093\/brain\/120.8.1485","volume":"120","author":"HW Moser","year":"1997","unstructured":"Moser HW. Adrenoleukodystrophy: phenotype, genetics, pathogenesis and therapy. Brain. 1997;120:1485\u2013508.","journal-title":"Brain"},{"key":"7893_CR346","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1111\/bpa.12601","volume":"28","author":"A Sosunov","year":"2018","unstructured":"Sosunov A, Olabarria M, Goldman JE. Alexander disease: an astrocytopathy that produces a leukodystrophy. Brain Pathol. 2018;28:388\u201398.","journal-title":"Brain Pathol"},{"key":"7893_CR347","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000209941","volume":"103","author":"H Tung","year":"2024","unstructured":"Tung H, Chou CC, Chen HM, Chen YM, Wu YY, Chai JW, et al. White Matter Hyperintensities and cognitive functions in people with the R544C variant of the NOTCH3 gene without stroke or dementia. Neurology. 2024;103:e209941.","journal-title":"Neurology"},{"key":"7893_CR348","doi-asserted-by":"crossref","unstructured":"Moser AB, Jones RO, Hubbard WC, Tortorelli S, Orsini JJ, Caggana M, et al. Newborn Screening for X-Linked Adrenoleukodystrophy. Int J Neonatal Screen. 2016;2:15.","DOI":"10.3390\/ijns2040015"},{"key":"7893_CR349","doi-asserted-by":"publisher","first-page":"3139","DOI":"10.1093\/brain\/awx262","volume":"140","author":"A Lauer","year":"2017","unstructured":"Lauer A, Da X, Hansen MB, Boulouis G, Ou Y, Cai X, et al. ABCD1 dysfunction alters white matter microvascular perfusion. Brain. 2017;140:3139\u201352.","journal-title":"Brain"},{"key":"7893_CR350","doi-asserted-by":"publisher","first-page":"9366","DOI":"10.1073\/pnas.94.17.9366","volume":"94","author":"JF Lu","year":"1997","unstructured":"Lu JF, Lawler AM, Watkins PA, Powers JM, Moser AB, Moser HW, et al. A mouse model for X-linked adrenoleukodystrophy. Proc Natl Acad Sci USA. 1997;94:9366\u201371.","journal-title":"Proc Natl Acad Sci USA"},{"key":"7893_CR351","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1002\/(SICI)1097-4547(19971201)50:5<829::AID-JNR19>3.0.CO;2-W","volume":"50","author":"S Forss-Petter","year":"1997","unstructured":"Forss-Petter S, Werner H, Berger J, Lassmann H, Molzer B, Schwab MH, et al. Targeted inactivation of the X-linked adrenoleukodystrophy gene in mice. J Neurosci Res. 1997;50:829\u201343.","journal-title":"J Neurosci Res"},{"key":"7893_CR352","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1006\/bbrc.1997.6340","volume":"232","author":"T Kobayashi","year":"1997","unstructured":"Kobayashi T, Shinnoh N, Kondo A, Yamada T. Adrenoleukodystrophy protein-deficient mice represent abnormality of very long chain fatty acid metabolism. Biochem Biophys Res Commun. 1997;232:631\u20136.","journal-title":"Biochem Biophys Res Commun"},{"key":"7893_CR353","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1093\/hmg\/11.5.499","volume":"11","author":"A Pujol","year":"2002","unstructured":"Pujol A, Hindelang C, Callizot N, Bartsch U, Schachner M, Mandel JL. Late onset neurological phenotype of the X-ALD gene inactivation in mice: a mouse model for adrenomyeloneuropathy. Hum Mol Genet. 2002;11:499\u2013505.","journal-title":"Hum Mol Genet"},{"key":"7893_CR354","doi-asserted-by":"publisher","first-page":"4176","DOI":"10.1111\/febs.15060","volume":"286","author":"HA Rutherford","year":"2019","unstructured":"Rutherford HA, Hamilton N. Animal models of leukodystrophy: a new perspective for the development of therapies. FEBS J. 2019;286:4176\u201391.","journal-title":"FEBS J"},{"key":"7893_CR355","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s40478-023-01595-w","volume":"11","author":"K Martinovi\u0107","year":"2023","unstructured":"Martinovi\u0107 K, Bauer J, Kunze M, Berger J, Forss-Petter S. Abcd1 deficiency accelerates cuprizone-induced oligodendrocyte loss and axonopathy in a demyelinating mouse model of X-linked adrenoleukodystrophy. Acta Neuropathol Commun. 2023;11:98.","journal-title":"Acta Neuropathol Commun"},{"key":"7893_CR356","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1111\/bpa.12595","volume":"28","author":"A Schl\u00fcter","year":"2018","unstructured":"Schl\u00fcter A, Sandoval J, Fourcade S, D\u00edaz-Lagares A, Ruiz M, Casaccia P, et al. Epigenomic signature of adrenoleukodystrophy predicts compromised oligodendrocyte differentiation. Brain Pathol. 2018;28:902\u201319.","journal-title":"Brain Pathol"},{"key":"7893_CR357","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.biochi.2013.11.023","volume":"98","author":"J Berger","year":"2014","unstructured":"Berger J, Forss-Petter S, Eichler FS. Pathophysiology of X-linked adrenoleukodystrophy. Biochimie. 2014;98:135\u201342.","journal-title":"Biochimie"},{"key":"7893_CR358","doi-asserted-by":"crossref","unstructured":"Hashemi E, Narain Srivastava I, Aguirre A, Tilahan Yoseph E, Kaushal E, Awani A, et al. A novel mouse model of cerebral adrenoleukodystrophy highlights NLRP3 activity in lesion pathogenesis. bioRxiv. 2023.11.07.564025.","DOI":"10.1101\/2023.11.07.564025"},{"key":"7893_CR359","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1002\/ana.27117","volume":"97","author":"E Hashemi","year":"2025","unstructured":"Hashemi E, Srivastava IN, Aguirre A, Yoseph ET, Kaushal E, Awani A, et al. A novel mouse model for cerebral inflammatory demyelination in X-Linked Adrenoleukodystrophy: Insights into pathogenesis and potential therapeutic targets. Ann Neurol. 2025;97:296\u2013312.","journal-title":"Ann Neurol"},{"key":"7893_CR360","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1007\/s00401-009-0591-3","volume":"118","author":"M Kipp","year":"2009","unstructured":"Kipp M, Clarner T, Dang J, Copray S, Beyer C. The cuprizone animal model: new insights into an old story. Acta Neuropathol. 2009;118:723\u201336.","journal-title":"Acta Neuropathol"},{"key":"7893_CR361","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-024-01771-1","volume":"29","author":"SC Chang","year":"2024","unstructured":"Chang SC, Eichinger CS, Field P. The natural history and burden of illness of metachromatic leukodystrophy: a systematic literature review. Eur J Med Res. 2024;29:181.","journal-title":"Eur J Med Res"},{"key":"7893_CR362","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.beem.2014.10.001","volume":"29","author":"DF van Rappard","year":"2015","unstructured":"van Rappard DF, Boelens JJ, Wolf NI. Metachromatic leukodystrophy: Disease spectrum and approaches for treatment. Best Pr Res Clin Endocrinol Metab. 2015;29:261\u201373.","journal-title":"Best Pr Res Clin Endocrinol Metab"},{"key":"7893_CR363","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1007\/s13311-023-01409-w","volume":"20","author":"M Mekhaeil","year":"2023","unstructured":"Mekhaeil M, Conroy MJ, Dev KK. Olaparib attenuates demyelination and neuroinflammation in an organotypic slice culture model of metachromatic leukodystrophy. Neurotherapeutics. 2023;20:1347\u201368.","journal-title":"Neurotherapeutics"},{"key":"7893_CR364","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtm.2024.101248","volume":"32","author":"E Audouard","year":"2024","unstructured":"Audouard E, Khefif N, Mansat C, Nelcha O, Banchi EG, Lupiet C, et al. Dose-response evaluation of intravenous gene therapy in a symptomatic mouse model of metachromatic leukodystrophy. Mol Ther Methods Clin Dev. 2024;32:101248.","journal-title":"Mol Ther Methods Clin Dev"},{"key":"7893_CR365","doi-asserted-by":"publisher","first-page":"14821","DOI":"10.1073\/pnas.93.25.14821","volume":"93","author":"B Hess","year":"1996","unstructured":"Hess B, Saftig P, Hartmann D, Coenen R, L\u00fcllmann-Rauch R, Goebel HH, et al. Phenotype of arylsulfatase A-deficient mice: relationship to human metachromatic leukodystrophy. Proc Natl Acad Sci USA. 1996;93:14821\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"7893_CR366","doi-asserted-by":"publisher","first-page":"3109","DOI":"10.1523\/JNEUROSCI.4366-05.2006","volume":"26","author":"MI Givogri","year":"2006","unstructured":"Givogri MI, Galbiati F, Fasano S, Amadio S, Perani L, Superchi D, et al. Oligodendroglial progenitor cell therapy limits central neurological deficits in mice with metachromatic leukodystrophy. J Neurosci. 2006;26:3109\u201319.","journal-title":"J Neurosci"},{"key":"7893_CR367","doi-asserted-by":"publisher","first-page":"3567","DOI":"10.1523\/JNEUROSCI.1829-22.2023","volume":"43","author":"T St Martin","year":"2023","unstructured":"St Martin T, Seabrook TA, Gall K, Newman J, Avila N, Hayes A, et al. Single systemic administration of a gene therapy leading to disease treatment in metachromatic leukodystrophy Arsa knock-out mice. J Neurosci. 2023;43:3567\u201381.","journal-title":"J Neurosci"},{"key":"7893_CR368","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-99979-2","volume":"11","author":"N Miyake","year":"2021","unstructured":"Miyake N, Miyake K, Sakai A, Yamamoto M, Suzuki H, Shimada T. Treatment of adult metachromatic leukodystrophy model mice using intrathecal administration of type 9 AAV vector encoding arylsulfatase A. Sci Rep. 2021;11:20513.","journal-title":"Sci Rep"},{"key":"7893_CR369","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-019-1220-4","volume":"14","author":"S Beerepoot","year":"2019","unstructured":"Beerepoot S, Nierkens S, Boelens JJ, Lindemans C, Bugiani M, Wolf NI. Peripheral neuropathy in metachromatic leukodystrophy: current status and future perspective. Orphanet J Rare Dis. 2019;14:240.","journal-title":"Orphanet J Rare Dis"},{"key":"7893_CR370","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2020.576221","volume":"7","author":"AA Shaimardanova","year":"2020","unstructured":"Shaimardanova AA, Chulpanova DS, Solovyeva VV, Mullagulova AI, Kitaeva KV, Allegrucci C, et al. Metachromatic Leukodystrophy: Diagnosis, modeling, and treatment approaches. Front Med. 2020;7:576221.","journal-title":"Front Med"},{"key":"7893_CR371","doi-asserted-by":"publisher","first-page":"9482","DOI":"10.1523\/JNEUROSCI.2287-07.2007","volume":"27","author":"H Ramakrishnan","year":"2007","unstructured":"Ramakrishnan H, Hedayati KK, L\u00fcllmann-Rauch R, Wessig C, Fewou SN, Maier H, et al. Increasing sulfatide synthesis in myelin-forming cells of arylsulfatase A-deficient mice causes demyelination and neurological symptoms reminiscent of human metachromatic leukodystrophy. J Neurosci. 2007;27:9482\u201390.","journal-title":"J Neurosci"},{"key":"7893_CR372","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1172\/JCI39733","volume":"120","author":"A Joutel","year":"2010","unstructured":"Joutel A, Monet-Lepr\u00eatre M, Gosele C, Baron-Menguy C, Hammes A, Schmidt S, et al. Cerebrovascular dysfunction and microcirculation rarefaction precede white matter lesions in a mouse genetic model of cerebral ischemic small vessel disease. J Clin Invest. 2010;120:433\u201345.","journal-title":"J Clin Invest"},{"key":"7893_CR373","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1016\/S0140-6736(97)08083-5","volume":"350","author":"A Joutel","year":"1997","unstructured":"Joutel A, Vahedi K, Corpechot C, Troesch A, Chabriat H, Vayssi\u00e8re C, et al. Strong clustering and stereotyped nature of Notch3 mutations in CADASIL patients. Lancet. 1997;350:1511\u20135.","journal-title":"Lancet"},{"key":"7893_CR374","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/2051-5960-2-49","volume":"2","author":"E Cognat","year":"2014","unstructured":"Cognat E, Cleophax S, Domenga-Denier V, Joutel A. Early white matter changes in CADASIL: evidence of segmental intramyelinic oedema in a pre-clinical mouse model. Acta Neuropathol Commun. 2014;2:49.","journal-title":"Acta Neuropathol Commun"},{"key":"7893_CR375","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s40478-015-0268-1","volume":"3","author":"JW Rutten","year":"2015","unstructured":"Rutten JW, Klever RR, Hegeman IM, Poole DS, Dauwerse HG, Broos LA, et al. The NOTCH3 score: a pre-clinical CADASIL biomarker in a novel human genomic NOTCH3 transgenic mouse model with early progressive vascular NOTCH3 accumulation. Acta Neuropathol Commun. 2015;3:89.","journal-title":"Acta Neuropathol Commun"},{"key":"7893_CR376","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/S0002-9440(10)63824-2","volume":"162","author":"MM Ruchoux","year":"2003","unstructured":"Ruchoux MM, Domenga V, Brulin P, Maciazek J, Limol S, Tournier-Lasserve E, et al. Transgenic mice expressing mutant Notch3 develop vascular alterations characteristic of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Am J Pathol. 2003;162:329\u201342.","journal-title":"Am J Pathol"},{"key":"7893_CR377","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1002\/ana.24512","volume":"78","author":"M Ghosh","year":"2015","unstructured":"Ghosh M, Balbi M, Hellal F, Dichgans M, Lindauer U, Plesnila N. Pericytes are involved in the pathogenesis of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Ann Neurol. 2015;78:887\u2013900.","journal-title":"Ann Neurol"},{"key":"7893_CR378","doi-asserted-by":"publisher","DOI":"10.1002\/adbi.202300439","volume":"8","author":"B Kastberger","year":"2024","unstructured":"Kastberger B, Winter S, Brandst\u00e4tter H, Biller J, Wagner W, Plesnila N. Treatment with Cerebrolysin prolongs lifespan in a mouse model of cerebral autosomal dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy. Adv Biol. 2024;8:e2300439.","journal-title":"Adv Biol"},{"key":"7893_CR379","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1111\/nan.12697","volume":"47","author":"RM Rajani","year":"2021","unstructured":"Rajani RM, Dupr\u00e9 N, Domenga-Denier V, Van Niel G, Heiligenstein X, Joutel A. Characterisation of early ultrastructural changes in the cerebral white matter of CADASIL small vessel disease using high-pressure freezing\/freeze-substitution. Neuropathol Appl Neurobiol. 2021;47:694\u2013704.","journal-title":"Neuropathol Appl Neurobiol"},{"key":"7893_CR380","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/brain\/72.3.373","volume":"72","author":"WS Alexander","year":"1949","unstructured":"Alexander WS. Progressive fibrinoid degeneration of fibrillary astrocytes associated with mental retardation in a hydrocephalic infant. Brain. 1949;72:373\u201381.","journal-title":"Brain"},{"key":"7893_CR381","first-page":"391","volume":"152","author":"A Messing","year":"1998","unstructured":"Messing A, Head MW, Galles K, Galbreath EJ, Goldman JE, Brenner M. Fatal encephalopathy with astrocyte inclusions in GFAP transgenic mice. Am J Pathol. 1998;152:391\u20138.","journal-title":"Am J Pathol"},{"key":"7893_CR382","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1002\/glia.20486","volume":"55","author":"KF Tanaka","year":"2007","unstructured":"Tanaka KF, Takebayashi H, Yamazaki Y, Ono K, Naruse M, Iwasato T, et al. Murine model of Alexander disease: analysis of GFAP aggregate formation and its pathological significance. Glia. 2007;55:617\u201331.","journal-title":"Glia"},{"key":"7893_CR383","doi-asserted-by":"publisher","first-page":"11162","DOI":"10.1523\/JNEUROSCI.3260-06.2006","volume":"26","author":"TL Hagemann","year":"2006","unstructured":"Hagemann TL, Connor JX, Messing A. Alexander disease-associated glial fibrillary acidic protein mutations in mice induce Rosenthal fiber formation and a white matter stress response. J Neurosci. 2006;26:11162\u201373.","journal-title":"J Neurosci"},{"key":"7893_CR384","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/apm.12088","volume":"122","author":"T Pekny","year":"2014","unstructured":"Pekny T, Faiz M, Wilhelmsson U, Curtis MA, Matej R, Skalli O, et al. Synemin is expressed in reactive astrocytes and Rosenthal fibers in Alexander disease. APMIS. 2014;122:76\u201380.","journal-title":"APMIS"},{"key":"7893_CR385","doi-asserted-by":"crossref","unstructured":"Cho ES, Han S, Kim G, Eom M, Lee KH, Kim CH, et al. In vivo whole-brain imaging of zebrafish larvae using three-dimensional fluorescence microscopy. J Vis Exp. 2023;194:65218.","DOI":"10.3791\/65218"},{"key":"7893_CR386","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s42826-021-00103-2","volume":"37","author":"CP Choe","year":"2021","unstructured":"Choe CP, Choi SY, Kee Y, Kim MJ, Kim SH, Lee Y, et al. Transgenic fluorescent zebrafish lines that have revolutionized biomedical research. Lab Anim Res. 2021;37:26.","journal-title":"Lab Anim Res"},{"key":"7893_CR387","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1002\/glia.24336","volume":"71","author":"MA Masson","year":"2023","unstructured":"Masson MA, Nait-Oumesmar B. Emerging concepts in oligodendrocyte and myelin formation, inputs from the zebrafish model. Glia. 2023;71:1147\u201363.","journal-title":"Glia"},{"key":"7893_CR388","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s40478-014-0077-y","volume":"2","author":"EJ M\u00fcnzel","year":"2014","unstructured":"M\u00fcnzel EJ, Becker CG, Becker T, Williams A. Zebrafish regenerate full thickness optic nerve myelin after demyelination, but this fails with increasing age. Acta Neuropathol Commun. 2014;2:77.","journal-title":"Acta Neuropathol Commun"},{"key":"7893_CR389","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1084\/jem.20191290","volume":"217","author":"G Okumura","year":"2020","unstructured":"Okumura G, Iguchi-Manaka A, Murata R, Yamashita-Kanemaru Y, Shibuya A, Shibuya K. Tumor-derived soluble CD155 inhibits DNAM-1-mediated antitumor activity of natural killer cells. J Exp Med. 2020;217:1.","journal-title":"J Exp Med"},{"key":"7893_CR390","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.654583","volume":"9","author":"AD Morris","year":"2021","unstructured":"Morris AD, Kucenas S. A Novel Lysolecithin model for visualizing damage in vivo in the larval Zebrafish spinal cord. Front Cell Dev Biol. 2021;9:654583.","journal-title":"Front Cell Dev Biol"},{"key":"7893_CR391","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/978-1-4939-9072-6_13","volume":"1936","author":"MJ Karttunen","year":"2019","unstructured":"Karttunen MJ, Lyons DA. A drug-inducible transgenic Zebrafish model for myelinating glial cell ablation. Methods Mol Biol. 2019;1936:227\u201338.","journal-title":"Methods Mol Biol"},{"key":"7893_CR392","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1007\/s10059-013-0087-9","volume":"36","author":"AY Chung","year":"2013","unstructured":"Chung AY, Kim PS, Kim S, Kim E, Kim D, Jeong I, et al. Generation of demyelination models by targeted ablation of oligodendrocytes in the zebrafish CNS. Mol Cells. 2013;36:82\u201387.","journal-title":"Mol Cells"},{"key":"7893_CR393","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1242\/bio.201410736","volume":"4","author":"Y Fang","year":"2014","unstructured":"Fang Y, Lei X, Li X, Chen Y, Xu F, Feng X, et al. A novel model of demyelination and remyelination in a GFP-transgenic zebrafish. Biol Open. 2014;4:62\u201368.","journal-title":"Biol Open"},{"key":"7893_CR394","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.cub.2018.01.017","volume":"28","author":"F Auer","year":"2018","unstructured":"Auer F, Vagionitis S, Czopka T. Evidence for Myelin sheath remodeling in the CNS Revealed by In Vivo Imaging. Curr Biol. 2018;28:549\u2013559.e543.","journal-title":"Curr Biol"},{"key":"7893_CR395","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.msard.2016.11.010","volume":"11","author":"P Kulkarni","year":"2017","unstructured":"Kulkarni P, Yellanki S, Medishetti R, Sriram D, Saxena U, Yogeeswari P. Novel Zebrafish EAE model: A quick in vivo screen for multiple sclerosis. Mult Scler Relat Disord. 2017;11:32\u201339.","journal-title":"Mult Scler Relat Disord"},{"key":"7893_CR396","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.661759","volume":"9","author":"C Gilardi","year":"2021","unstructured":"Gilardi C, Kalebic N. The Ferret as a model system for neocortex development and evolution. Front Cell Dev Biol. 2021;9:661759.","journal-title":"Front Cell Dev Biol"},{"key":"7893_CR397","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1093\/cercor\/bhq238","volume":"21","author":"I Reillo","year":"2011","unstructured":"Reillo I, de Juan Romero C, Garc\u00eda-Cabezas M, Borrell V. A role for intermediate radial glia in the tangential expansion of the mammalian cerebral cortex. Cereb Cortex. 2011;21:1674\u201394.","journal-title":"Cereb Cortex"},{"key":"7893_CR398","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1159\/000498968","volume":"40","author":"T Wood","year":"2018","unstructured":"Wood T, Moralejo D, Corry K, Snyder JM, Traudt C, Curtis C, et al. A Ferret Model of Encephalopathy of prematurity. Dev Neurosci. 2018;40:475\u201389.","journal-title":"Dev Neurosci"},{"key":"7893_CR399","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.expneurol.2013.06.004","volume":"248","author":"DL Di Curzio","year":"2013","unstructured":"Di Curzio DL, Buist RJ, Del Bigio MR. Reduced subventricular zone proliferation and white matter damage in juvenile ferrets with kaolin-induced hydrocephalus. Exp Neurol. 2013;248:112\u201328.","journal-title":"Exp Neurol"},{"key":"7893_CR400","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1016\/j.neuron.2020.09.033","volume":"108","author":"M Chavali","year":"2020","unstructured":"Chavali M, Ulloa-Navas MJ, P\u00e9rez-Borred\u00e1 P, Garcia-Verdugo JM, McQuillen PS, Huang EJ, et al. Wnt-Dependent Oligodendroglial-endothelial interactions regulate white matter vascularization and attenuate injury. Neuron. 2020;108:1130\u20131145.e1135.","journal-title":"Neuron"},{"key":"7893_CR401","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-47900-4","volume":"13","author":"C Walter","year":"2023","unstructured":"Walter C, Balouchzadeh R, Garcia KE, Kroenke CD, Pathak A, Bayly PV. Multi-scale measurement of stiffness in the developing ferret brain. Sci Rep. 2023;13:20583.","journal-title":"Sci Rep"},{"key":"7893_CR402","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1002\/jnr.24218","volume":"96","author":"SC Schwerin","year":"2018","unstructured":"Schwerin SC, Chatterjee M, Imam-Fulani AO, Radomski KL, Hutchinson EB, Pierpaoli CM, et al. Progression of histopathological and behavioral abnormalities following mild traumatic brain injury in the male ferret. J Neurosci Res. 2018;96:556\u201372.","journal-title":"J Neurosci Res"},{"key":"7893_CR403","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1089\/neur.2023.0047","volume":"4","author":"JL Krieg","year":"2023","unstructured":"Krieg JL, Leonard AV, Tuner RJ, Corrigan F. Characterization of traumatic brain injury in a Gyrencephalic Ferret Model Using the Novel Closed Head Injury Model of Engineered Rotational Acceleration (CHIMERA). Neurotrauma Rep. 2023;4:761\u201380.","journal-title":"Neurotrauma Rep"},{"key":"7893_CR404","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1007\/s11357-011-9357-7","volume":"34","author":"SG Kohama","year":"2012","unstructured":"Kohama SG, Rosene DL, Sherman LS. Age-related changes in human and non-human primate white matter: from myelination disturbances to cognitive decline. Age. 2012;34:1093\u2013110.","journal-title":"Age"},{"key":"7893_CR405","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2021.117825","volume":"231","author":"N Aggarwal","year":"2021","unstructured":"Aggarwal N, Moody JF, Dean DC, Tromp DPM, Kecskemeti SR, Oler JA, et al. Spatiotemporal dynamics of nonhuman primate white matter development during the first year of life. Neuroimage. 2021;231:117825.","journal-title":"Neuroimage"},{"key":"7893_CR406","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1080\/17470919.2015.1087426","volume":"10","author":"MM Sanchez","year":"2015","unstructured":"Sanchez MM, McCormack KM, Howell BR. Social buffering of stress responses in nonhuman primates: Maternal regulation of the development of emotional regulatory brain circuits. Soc Neurosci. 2015;10:512\u201326.","journal-title":"Soc Neurosci"},{"key":"7893_CR407","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/2045-5380-3-21","volume":"3","author":"BR Howell","year":"2013","unstructured":"Howell BR, McCormack KM, Grand AP, Sawyer NT, Zhang X, Maestripieri D, et al. Brain white matter microstructure alterations in adolescent rhesus monkeys exposed to early life stress: associations with high cortisol during infancy. Biol Mood Anxiety Disord. 2013;3:21.","journal-title":"Biol Mood Anxiety Disord"},{"key":"7893_CR408","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jneuroim.2005.05.017","volume":"168","author":"BA t Hart","year":"2005","unstructured":"t Hart BA, Bauer J, Brok HP, Amor S. Non-human primate models of experimental autoimmune encephalomyelitis: Variations on a theme. J Neuroimmunol. 2005;168:1\u201312.","journal-title":"J Neuroimmunol"},{"key":"7893_CR409","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/S1474-4422(04)00879-8","volume":"3","author":"BA t Hart","year":"2004","unstructured":"t Hart BA, Laman JD, Bauer J, Blezer E, van Kooyk Y, Hintzen RQ. Modelling of multiple sclerosis: lessons learned in a non-human primate. Lancet Neurol. 2004;3:588\u201397.","journal-title":"Lancet Neurol"},{"key":"7893_CR410","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2021.113655","volume":"340","author":"S Li","year":"2021","unstructured":"Li S, Rao JH, Lan XY, Li X, Chu CY, Liang Y, et al. White matter demyelination predates axonal injury after ischemic stroke in cynomolgus monkeys. Exp Neurol. 2021;340:113655.","journal-title":"Exp Neurol"},{"key":"7893_CR411","doi-asserted-by":"publisher","DOI":"10.3389\/fnsys.2021.760311","volume":"15","author":"N Higo","year":"2021","unstructured":"Higo N. Non-human primate models to explore the adaptive mechanisms after stroke. Front Syst Neurosci. 2021;15:760311.","journal-title":"Front Syst Neurosci"},{"key":"7893_CR412","doi-asserted-by":"publisher","first-page":"413","DOI":"10.4103\/1673-5374.245334","volume":"14","author":"HA Kinder","year":"2019","unstructured":"Kinder HA, Baker EW, West FD. The pig as a preclinical traumatic brain injury model: current models, functional outcome measures, and translational detection strategies. Neural Regen Res. 2019;14:413\u201324.","journal-title":"Neural Regen Res"},{"key":"7893_CR413","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneumeth.2025.110408","volume":"418","author":"VH Kuang","year":"2025","unstructured":"Kuang VH, Skoven CS, Arvin S, Fitting LM, Drasbek KR, Hansen B, et al. A large animal model for focal stroke: Photothrombotic lesion in the cortex of Danish Landrace pigs. J Neurosci Methods. 2025;418:110408.","journal-title":"J Neurosci Methods"},{"key":"7893_CR414","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.jneumeth.2017.12.017","volume":"296","author":"MC Ryan","year":"2018","unstructured":"Ryan MC, Sherman P, Rowland LM, Wijtenburg SA, Acheson A, Fieremans E, et al. Miniature pig model of human adolescent brain white matter development. J Neurosci Methods. 2018;296:99\u2013108.","journal-title":"J Neurosci Methods"},{"key":"7893_CR415","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s13311-012-0108-y","volume":"9","author":"SA Back","year":"2012","unstructured":"Back SA, Riddle A, Dean J, Hohimer AR. The instrumented fetal sheep as a model of cerebral white matter injury in the premature infant. Neurotherapeutics. 2012;9:359\u201370.","journal-title":"Neurotherapeutics"},{"key":"7893_CR416","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1242\/dmm.002915","volume":"3","author":"JC Silbereis","year":"2010","unstructured":"Silbereis JC, Huang EJ, Back SA, Rowitch DH. Towards improved animal models of neonatal white matter injury associated with cerebral palsy. Dis Model Mech. 2010;3:678\u201388.","journal-title":"Dis Model Mech"},{"key":"7893_CR417","doi-asserted-by":"crossref","unstructured":"Banstola A, Reynolds JNJ. The Sheep as a Large Animal Model for the Investigation and Treatment of Human Disorders. Biology (Basel). 2022;11:1251.","DOI":"10.3390\/biology11091251"},{"key":"7893_CR418","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.cell.2014.04.052","volume":"158","author":"TJ Yuen","year":"2014","unstructured":"Yuen TJ, Silbereis JC, Griveau A, Chang SM, Daneman R, Fancy SPJ, et al. Oligodendrocyte-encoded HIF function couples postnatal myelination and white matter angiogenesis. Cell. 2014;158:383\u201396.","journal-title":"Cell"},{"key":"7893_CR419","first-page":"2147","volume":"18","author":"JP Templeton","year":"2012","unstructured":"Templeton JP, Geisert EE. A practical approach to optic nerve crush in the mouse. Mol Vis. 2012;18:2147\u201352.","journal-title":"Mol Vis"},{"key":"7893_CR420","doi-asserted-by":"crossref","unstructured":"Xing J, Lukomska A, Rheaume BA, Kim J, Sajid MS, Damania A, et al. Post-injury born oligodendrocytes incorporate into the glial scar and contribute to the inhibition of axon regeneration. Development. 2023;150:dev201311.","DOI":"10.1242\/dev.201311"},{"key":"7893_CR421","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.brainresbull.2020.11.012","volume":"166","author":"HR Mendon\u00e7a","year":"2021","unstructured":"Mendon\u00e7a HR, Villas Boas COG, Heringer LDS, Oliveira JT, Martinez AMB. Myelination of regenerating optic nerve axons occurs in conjunction with an increase of the oligodendrocyte precursor cell population in the adult mice. Brain Res Bull. 2021;166:150\u201360.","journal-title":"Brain Res Bull"},{"key":"7893_CR422","doi-asserted-by":"publisher","first-page":"10285","DOI":"10.1523\/JNEUROSCI.4915-13.2014","volume":"34","author":"JP Rodriguez","year":"2014","unstructured":"Rodriguez JP, Coulter M, Miotke J, Meyer RL, Takemaru K, Levine JM. Abrogation of \u03b2-catenin signaling in oligodendrocyte precursor cells reduces glial scarring and promotes axon regeneration after CNS injury. J Neurosci. 2014;34:10285\u201397.","journal-title":"J Neurosci"},{"key":"7893_CR423","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2024.1345042","volume":"18","author":"B Hawker","year":"2024","unstructured":"Hawker B, Dhakal M, Connor B, McCaughey-Chapman A. Modeling demyelination and endogenous remyelination in spinal cord ex vivo rat organotypic slice cultures. Front Cell Neurosci. 2024;18:1345042.","journal-title":"Front Cell Neurosci"},{"key":"7893_CR424","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/978-1-4939-9072-6_10","volume":"1936","author":"S Sekizar","year":"2019","unstructured":"Sekizar S, Williams A. Ex vivo slice cultures to study myelination, demyelination, and remyelination in mouse brain and spinal cord. Methods Mol Biol. 2019;1936:169\u201383.","journal-title":"Methods Mol Biol"},{"key":"7893_CR425","doi-asserted-by":"crossref","unstructured":"Shen K, Yuen TJ. Ex vivo myelination and remyelination in cerebellar slice cultures as a quantitative model for developmental and disease-relevant manipulations. J Vis Exp. 2020;160:61044.","DOI":"10.3791\/61044"},{"key":"7893_CR426","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1080\/17460441.2017.1356285","volume":"12","author":"F Doussau","year":"2017","unstructured":"Doussau F, Dupont JL, Neel D, Schneider A, Poulain B, Bossu JL. Organotypic cultures of cerebellar slices as a model to investigate demyelinating disorders. Expert Opin Drug Discov. 2017;12:1011\u201322.","journal-title":"Expert Opin Drug Discov"},{"key":"7893_CR427","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1002\/glia.24001","volume":"69","author":"L Baudouin","year":"2021","unstructured":"Baudouin L, Ad\u00e8s N, Kant\u00e9 K, Czarnecki A, Bachelin C, Baskaran A, et al. Co-culture of exogenous oligodendrocytes with unmyelinated cerebella: Revisiting ex vivo models and new tools to study myelination. Glia. 2021;69:1916\u201331.","journal-title":"Glia"},{"key":"7893_CR428","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2021.103276","volume":"65","author":"A Manousi","year":"2021","unstructured":"Manousi A, G\u00f6ttle P, Reiche L, Cui QL, Healy LM, Akkermann R, et al. Identification of novel myelin repair drugs by modulation of oligodendroglial differentiation competence. EBioMedicine. 2021;65:103276.","journal-title":"EBioMedicine"},{"key":"7893_CR429","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/nature14335","volume":"522","author":"FJ Najm","year":"2015","unstructured":"Najm FJ, Madhavan M, Zaremba A, Shick E, Karl RT, Factor DC, et al. Drug-based modulation of endogenous stem cells promotes functional remyelination in vivo. Nature. 2015;522:216\u201320.","journal-title":"Nature"},{"key":"7893_CR430","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s40478-016-0309-4","volume":"4","author":"X Yao","year":"2016","unstructured":"Yao X, Su T, Verkman AS. Clobetasol promotes remyelination in a mouse model of neuromyelitis optica. Acta Neuropathol Commun. 2016;4:42.","journal-title":"Acta Neuropathol Commun"},{"key":"7893_CR431","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s40478-024-01784-1","volume":"12","author":"BC Plug","year":"2024","unstructured":"Plug BC, Revers IM, Breur M, Gonz\u00e1lez GM, Timmerman JA, Meijns NRC, et al. Human post-mortem organotypic brain slice cultures: a tool to study pathomechanisms and test therapies. Acta Neuropathol Commun. 2024;12:83.","journal-title":"Acta Neuropathol Commun"},{"key":"7893_CR432","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1016\/j.devcel.2021.04.006","volume":"56","author":"OG James","year":"2021","unstructured":"James OG, Selvaraj BT, Magnani D, Burr K, Connick P, Barton SK, et al. iPSC-derived myelinoids to study myelin biology of humans. Dev Cell. 2021;56:1346\u20131358.e1346.","journal-title":"Dev Cell"},{"key":"7893_CR433","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2021.748849","volume":"15","author":"D Marangon","year":"2021","unstructured":"Marangon D, Caporale N, Boccazzi M, Abbracchio MP, Testa G, Lecca D. Novel in vitro experimental approaches to study myelination and remyelination in the central nervous system. Front Cell Neurosci. 2021;15:748849.","journal-title":"Front Cell Neurosci"},{"key":"7893_CR434","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.stemcr.2015.11.013","volume":"6","author":"S Kawabata","year":"2016","unstructured":"Kawabata S, Takano M, Numasawa-Kuroiwa Y, Itakura G, Kobayashi Y, Nishiyama Y, et al. Grafted human iPS cell-derived Oligodendrocyte precursor cells contribute to robust remyelination of demyelinated axons after spinal cord injury. Stem Cell Rep. 2016;6:1\u20138.","journal-title":"Stem Cell Rep"},{"key":"7893_CR435","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1016\/j.stemcr.2023.04.010","volume":"18","author":"R Martinez-Curiel","year":"2023","unstructured":"Martinez-Curiel R, Jansson L, Tsupykov O, Avaliani N, Aretio-Medina C, Hidalgo I, et al. Oligodendrocytes in human induced pluripotent stem cell-derived cortical grafts remyelinate adult rat and human cortical neurons. Stem Cell Rep. 2023;18:1643\u201356.","journal-title":"Stem Cell Rep"},{"key":"7893_CR436","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.stem.2023.04.011","volume":"30","author":"JJ Vandana","year":"2023","unstructured":"Vandana JJ, Manrique C, Lacko LA, Chen S. Human pluripotent-stem-cell-derived organoids for drug discovery and evaluation. Cell Stem Cell. 2023;30:571\u201391.","journal-title":"Cell Stem Cell"},{"key":"7893_CR437","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20440-5","volume":"12","author":"JC Park","year":"2021","unstructured":"Park JC, Jang SY, Lee D, Lee J, Kang U, Chang H, et al. A logical network-based drug-screening platform for Alzheimer\u2019s disease representing pathological features of human brain organoids. Nat Commun. 2021;12:280.","journal-title":"Nat Commun"},{"key":"7893_CR438","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aat5847","volume":"4","author":"T Osaki","year":"2018","unstructured":"Osaki T, Uzel SGM, Kamm RD. Microphysiological 3D model of amyotrophic lateral sclerosis (ALS) from human iPS-derived muscle cells and optogenetic motor neurons. Sci Adv. 2018;4:eaat5847.","journal-title":"Sci Adv"},{"key":"7893_CR439","doi-asserted-by":"crossref","unstructured":"GBD 2021 Diseases and Injuries Collaborators. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet 2024;403:2133\u201361.","DOI":"10.1016\/S0140-6736(24)00757-8"},{"key":"7893_CR440","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1007\/s00204-022-03299-x","volume":"96","author":"F Caloni","year":"2022","unstructured":"Caloni F, De Angelis I, Hartung T. Replacement of animal testing by integrated approaches to testing and assessment (IATA): a call for in vivitrosi. Arch Toxicol. 2022;96:1935\u201350.","journal-title":"Arch Toxicol"},{"key":"7893_CR441","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.jsps.2018.03.006","volume":"26","author":"J Rai","year":"2018","unstructured":"Rai J, Kaushik K. Reduction of animal sacrifice in biomedical science & research through alternative design of animal experiments. Saudi Pharm J. 2018;26:896\u2013902.","journal-title":"Saudi Pharm J"},{"key":"7893_CR442","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1093\/hmg\/ddh019","volume":"13","author":"JL Jankowsky","year":"2004","unstructured":"Jankowsky JL, Fadale DJ, Anderson J, Xu GM, Gonzales V, Jenkins NA, et al. Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase. Hum Mol Genet. 2004;13:159\u201370.","journal-title":"Hum Mol Genet"},{"key":"7893_CR443","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1080\/15548627.2018.1531196","volume":"15","author":"Y Liu","year":"2019","unstructured":"Liu Y, Xue X, Zhang H, Che X, Luo J, Wang P, et al. Neuronal-targeted TFEB rescues dysfunction of the autophagy-lysosomal pathway and alleviates ischemic injury in permanent cerebral ischemia. Autophagy. 2019;15:493\u2013509.","journal-title":"Autophagy"},{"key":"7893_CR444","first-page":"657","volume":"28","author":"C Schleicher","year":"1987","unstructured":"Schleicher C, Starker K, Burkhardt B, Starker W. Value of hysterosalpingography in the diagnosis of sterility. Radio Diagn. 1987;28:657\u201367.","journal-title":"Radio Diagn"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07893-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07893-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07893-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T11:28:17Z","timestamp":1757330897000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07893-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,31]]},"references-count":444,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7893"],"URL":"https:\/\/doi.org\/10.1038\/s41419-025-07893-6","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,31]]},"assertion":[{"value":"3 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"580"}}